US20050175649A1 - Enhancing properties by the use of nanoparticles - Google Patents

Enhancing properties by the use of nanoparticles Download PDF

Info

Publication number
US20050175649A1
US20050175649A1 US10/979,365 US97936504A US2005175649A1 US 20050175649 A1 US20050175649 A1 US 20050175649A1 US 97936504 A US97936504 A US 97936504A US 2005175649 A1 US2005175649 A1 US 2005175649A1
Authority
US
United States
Prior art keywords
metal
nanoparticle
composite material
agents
exfoliated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/979,365
Inventor
Anthony DiSalvo
Carolyn Mordas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nano Met-Zero Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Priority to US10/979,365 priority Critical patent/US20050175649A1/en
Assigned to MCNEIL-PPC, INC. reassignment MCNEIL-PPC, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DISALVO, ANTHONY L., MORDAS, CAROLYN J.
Publication of US20050175649A1 publication Critical patent/US20050175649A1/en
Priority to US13/792,478 priority patent/US20130189334A1/en
Assigned to DISALVO, ANTHONY L. reassignment DISALVO, ANTHONY L. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MCNEIL-PPC, INC.
Assigned to NANO MET-ZERO, INC. reassignment NANO MET-ZERO, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DISALVO, ANTHONY L.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28Microcapsules or nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84Accessories, not otherwise provided for, for absorbent pads
    • A61F13/8405Additives, e.g. for odour, disinfectant or pH control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • A61K8/0245Specific shapes or structures not provided for by any of the groups of A61K8/0241
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5115Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D1/00Coating compositions, e.g. paints, varnishes or lacquers, based on inorganic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84Accessories, not otherwise provided for, for absorbent pads
    • A61F13/8405Additives, e.g. for odour, disinfectant or pH control
    • A61F2013/8408Additives, e.g. for odour, disinfectant or pH control with odour control
    • A61F2013/8426Additives, e.g. for odour, disinfectant or pH control with odour control with metallic salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60Particulates further characterized by their structure or composition
    • A61K2800/61Surface treated
    • A61K2800/62Coated
    • A61K2800/621Coated by inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104Silver, e.g. silver sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/62Encapsulated active agents, e.g. emulsified droplets
    • A61L2300/624Nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991Coated

Definitions

  • the present invention relates to composite materials that are functionalized nanoparticles and in particular, metal-loaded nanoclays. Additionally, the present invention relates to a method of forming such composite materials.
  • silver metal has been known to be an agent capable of killing many different microbial species. It was commonly used to purify drinking solutions or administered to sick individuals before the existence of modern antibiotics. Even after the discovery of penicillin and its descendents, colloidal silver solutions were often used in cases in which troublesome bacteria had become resistant to antibiotics.
  • Colloidal silver solutions are commercially available today. They are often unstable, however, and have a short shelf life. This is due to the tendency of the silver particles to aggregate and form clusters so large that they are no longer suspended in solution. For this reason, undesirable gelling agents are added to solutions to keep the silver particles suspended by preventing particle aggregation.
  • Another problem of the commercially available solutions is that the majority of the silver content is usually found to be silver ions. This poses a large problem in medical applications where silver ions rapidly combine with ubiquitous chloride to form an insoluble white precipitate.
  • Nanoparticles have been known to be used as fillers as disclosed in U.S. Pat. No. 6,492,453, as coatings as disclosed in U.S. 2003/0185964 and as foam components as disclosed in U.S. Pat. No. 6,518,324.
  • Nanoparticle systems are disclosed in U.S. 2002/0150678 as being used in a composition and a method to impart surface modifying benefits to soft and hard surfaces.
  • this application discloses a soft surface coating for articles such as fabrics and garments.
  • Inorganic particulates such as, clays, silicates, and alumina have been widely used in combination with adjunct detergent and laundry compounds to impart some form of antistatic control and/or fabric softening benefit.
  • the present invention relates to composite materials comprising metal loaded onto exfoliated nanoparticles.
  • Such functionalized nanoparticles may be incorporated into solid and liquid materials to enhance or modify their bulk physical and performance characteristics.
  • the metal is silver and the nanoparticle comprises a nanoclay.
  • Silver ion is reduced to its neutral metal state (Ag 0 ) and loaded onto the nanoclay.
  • Silver-coated nanoclays in particular have excellent antimicrobial properties, and represent a less expensive alternative to the use of colloidal silver solutions.
  • Such nanoparticles made according to the invention are stable and use less silver metal to generate the same surface area as solid silver particles, making them more cost efficient.
  • the invention provides a composite material comprising (a) an exfoliated nanoparticle having a surface and (b) a metal selected from Groups 3 to 12, aluminum and magnesium, wherein the metal is loaded onto the surface of the nanoparticle.
  • the invention further provides solutions, solids, gels, coating compositions, cosmetic and pharmaceutical compositions, and articles of manufacture comprising such a composite material.
  • FIG. 1 shows the particle size distribution of the material of Example 1.
  • FIG. 2 shows the particle size distribution of the material of Example 5.
  • FIG. 3 shows the particle size distribution of the material of Example 6.
  • FIG. 4 shows the particle size distribution of the material of Example 7.
  • Every limit given throughout this specification includes every lower or higher limit, as the case may be, as if such lower or higher limit was expressly written herein. Every range given throughout this specification includes every narrower range that falls within such broader range, as if such narrower ranges were all expressly written herein.
  • Nanoparticles as used herein means particles (including but not limited to rod-shaped particles, disc-shaped particles, platelet-shaped particles, tetrahedral-shaped particles), fibers, nanotubes, or any other materials having dimensions on the nano scale.
  • the nanoparticles have an average particle size of about 1 to about 1000 nanometers, preferably 2 to about 750 nanometers. That is, the nanoparticles have a largest dimension (e.g., a diameter or length) of about 1 to 1000 nm.
  • Nanotubes can include structures up to 1 centimeter long, alternatively with a particle size from about 2 to about 50 nanometers. Nanoparticles have very high surface-to-volume ratios.
  • the nanoparticles may be crystalline or amorphous.
  • Non-limiting examples of suitable particle size distributions of nanoparticles are those within the range of about 2 nm to less than about 750 nm, alternatively from about 2 nm to less than about 200 nm, and alternatively from about 2 nm to less than about 150 nm. It should also be understood that certain particle size distributions may be useful to provide certain benefits, and other ranges of particle size distributions may be useful to provide other benefits (for instance, color enhancement requires a different particle size range than the other properties).
  • the average particle size of a batch of nanoparticles may differ from the particle size distribution of those nanoparticles.
  • a layered synthetic silicate can have an average particle size of about 25 nanometers while its particle size distribution can generally vary between about 10 nm to about 40 nm. It should be understood that the particle size distributions described herein are for nanoparticles when they are dispersed in an aqueous medium and the average particle size is based on the mean of the particle size distribution.
  • the nanoparticles are exfoliated.
  • a starting material is exfoliated or disbursed to form the nanoparticles.
  • Such starting material may have an average size of up to about 50 microns (50,000 nanometers).
  • the nanoparticle may comprise for example natural or synthetic nanoclays, including those made from amorphous or structured clays.
  • the exfoliated nanoparticle is a nanoclay.
  • the nanoparticle is a swellable nanoclay or adduct thereof.
  • a swellable nanoclay has weakly bound ions in interlayer positions that may be hydrated or may absorb organic solvents. These swellable nanoclays generally possess a low cationic or anionic charge, i.e. less than about 0.9 units of charge per unit cell.
  • swellable nanoclays i.e. those that swell in organic, non-aqueous solvents such as polar and nonpolar solvents. They may be prepared by reacting a water swellable nanoclay with an organic material that binds to the swellable nanoclay. Examples of such binding organic materials include, but are not limited to, a quaternary ammonium compound having the structure: R 1 R 2 R 3 R 4 N+ X- wherein
  • R 1 , R 2 , R 3 and R 4 are each independently selected from H, a C 1 to C 22 alkyl, a C 1 to C 22 alkenyl, and a C 1 to C 22 aralkyl, provided that at least one of the R groups is such an alkyl, alkenyl or aralkyl; and
  • X is the water swellable nanoclay.
  • the swellable nanoclay may be amorphous or structured, i.e., including sheets or layers, wherein a combination of such layers is referred to as a lattice structure.
  • suitable nanoclays having lattice structures include the pyrophillite (dioctahedral) type, the talc (trioctahedral) type, or mixtures thereof.
  • Classes of suitable structured swellable nanoclays include, but are not limited to the smectite nanoclays, sepiolite nanoclays, zeolite nanoclays, palygorskite nanoclays, or mixtures thereof.
  • amorphous swellable nanoclays examples include allophone and imogolite.
  • the nanoparticles are made from a starting material such as Nanomer 1.34TCN (available from Nanocor) having a particle size of 10 to 18 microns (10000-18000 nanometers).
  • the nanoparticles are made from PGV (also available from Nanocor) having a particle size of 20 to 25 microns.
  • exfoliated PGV having a particle size range of 1-3 nanometers is used.
  • Nanomer 1.34TCN and Nanomer 1.30E having a particle size range of 1-9 nanometers is used.
  • Layered clay minerals can be used as starting materials for the exfoliated nanoparticles.
  • the layered clay minerals suitable for use in the present invention include those in the geological classes of the smectites, the kaolins, the illites, the chlorites, the attapulgites and the mixed layer clays. Typical examples of specific clays belonging to these classes are the smectices, kaolins, illites, chlorites, attapulgites and mixed layer clays.
  • Smectites for example, include montmorillonite, bentonite, pyrophyllite, hectorite, saponite, sauconite, nontronite, talc, beidellite, volchonskoite, stevensite, and vermiculite.
  • montmorillonite nanoclay is preferred. See U.S. Pat. No. 5,869,033, which is incorporated by reference herein.
  • Kaolins include kaolinite, dickite, nacrite, antigorite, anauxite, halloysite, indellite and chrysotile.
  • Illites include bravaisite, muscovite, paragonite, phlogopite and biotite.
  • Chlorites include corrensite, penninite, donbassite, sudoite, pennine and clinochlore.
  • Attapulgites include sepiolite and polygorskyte.
  • Mixed layer clays include allevardite and vermiculitebiotite. Variants and isomorphic substitutions of these layered clay minerals offer unique applications.
  • Layered clay minerals may be either naturally occurring or synthetic.
  • natural or synthetic hectorites, montmorillonites and bentonites may be used as the starting material for the nanoparticles.
  • Natural clay minerals typically exist as layered silicate minerals and less frequently as amorphous minerals.
  • a layered silicate mineral has SiO 4 tetrahedral sheets arranged into a two-dimensional network structure.
  • a 2:1 type layered silicate mineral has a laminated structure of several to several tens of silicate sheets having a three layered structure in which a magnesium octahedral sheet or an aluminum octahedral sheet is sandwiched between two sheets of silica tetrahedral sheets.
  • a sheet of an expandable layer silicate has a negative electric charge, and the electric charge is neutralized by the existence of alkali metal cations and/or alkaline earth metal cations.
  • Smectite or expandable mica can be dispersed in water to form a sol with thixotropic properties.
  • a complex variant of the smectite type clay can be formed by the reaction with various cationic organic or inorganic compounds.
  • An example of such an organic complex an organophilic clay in which a dimethyldioctadecyl ammonium ion (a quaternary ammonium ion) is introduced by cation exchange. This has been industrially produced and used as a gellant of a coating.
  • Synthetic nanoclays may be employed in the invention. With appropriate process control, the processes for the production of synthetic nanoclays does indeed yield primary particles that are nanoscale. However, the particles are not usually present in the form of discrete particles, but instead predominantly assume the form of agglomerates due to consolidation of the primary particles. Such agglomerates may reach diameters of several thousand nanometers, such that the desired characteristics associated with the nanoscale nature of the particles cannot be achieved.
  • the particles may be deagglomerated, for example, by grinding as described in EP-A 637,616 or by dispersion in a suitable carrier medium, such as water or water/alcohol and mixtures thereof.
  • Synthetic materials for making suitable nanoclays include layered hydrous silicate, layered hydrous aluminum silicate, fluorosilicate, mica-montmorillonite, hydrotalcite, lithium magnesium silicate and lithium magnesium fluorosilicate.
  • An example of a substituted variant of lithium magnesium silicate is where the hydroxyl group is partially substituted with fluorine.
  • Lithium and magnesium may also be partially substituted by aluminum.
  • Lithium magnesium silicate may be isomorphically substituted by any member selected from the group consisting of magnesium, aluminum, lithium, iron, chromium, zinc and mixtures thereof.
  • Synthetic hectorite for example as commercially marketed under the trade name LAPONITETM by Southern Clay Products, Inc., may be used as a starting material for the nanoparticles. There are many grades or variants and isomorphous substitutions of LAPONITETM marketed. Examples of commercial hectorites are LAPONITE BTM, LAPONITE STM, LAPONITE XLSTM, LAPONITE RDTM, LAPONITE XLGTM, and LAPONITE RDSTM.
  • Synthetic hectorites do not contain any fluorine.
  • An isomorphous substitution of the hydroxyl group with fluorine will produce synthetic clays referred to as sodium magnesium lithium fluorosilicates, which may also be used as the starting material.
  • These sodium magnesium lithium fluorosilicates marketed as LAPONITETM and LAPONITE STM, may contain fluoride ions of up to approximately 10% by weight.
  • the fluoride ion content useful in the compositions described herein is up to about 10 or more percent.
  • LAPONITE BTM a sodium magnesium lithium fluorosilicate, has a flat, circular, plate-like shape, with an average particle size, depending on fluoride ion content, of about 25-100 nanometers.
  • LAPONITE BTM having a diameter of about 25-40 nmand and thinkness of about 1 nm may be used.
  • Laponite XLSTM is used as the starting material for the nanoparticle, and silver is loaded thereon as the metal.
  • Laponite XLS has tetrahedral silicate layers joined by octahedral magnesium and lithium hydroxyl bridges. This structure allows for exfoliation and modification by either intercalation or adsorption of metal to the nanoclay surface. In the case of intercalation, the metal is inserted between the layers of nanoclay. In the case of surface adsorption, the metal binds to the surface of the nanoclay. Laponite XLS is advantageous because it is synthetically consistent and pure, and exfoliates to form nanoparticles with minimal effort. The surface of the nanoparticle is covered with sodium ions to balance out the negative charge of the many silicate groups.
  • the aspect ratio of the exfoliated nanoparticles in some cases, is of interest in forming films comprising the composite material with desired characteristics.
  • the aspect ratio of dispersions can be adequately characterized by TEM (transmission electron microscopy).
  • the aspect ratio of nanoparticles in one embodiment can be in the range of 100 to 250. In another embodiment, the aspect ratio of the nanoparticles is 200 to 350.
  • the average aspect ratio of individual particles of LAPONITE BTM is approximately 20-40 and the average aspect ratio of individual particles of LAPONITE RDTM is approximately 10-15.
  • LAPONITE BTM occurs in dispersions as essentially single clay particles or stacks of two clay particles.
  • LAPONITE RDTM occurs essentially as stacks of two or more single clay particles.
  • a high aspect ratio may be desirable for film formation.
  • the aspect ratio of exfoliated nanoparticles dispersed in a suitable carrier medium, such as water, is also of interest.
  • the aspect ratio of the nanoparticles in a dispersed medium is lower where several of the particles are aggregated.
  • the aspect ratio of rod-shaped nanoparticles can be lower than that of disc-shaped or platelet-shaped nanoparticles while maintaining adequate film-forming properties.
  • the aspect ratio of spheroid-shaped nanoparticles is generally less than or equal to about 5.
  • Nanoparticles preferred for the embodiments presented here have aspect ratios of less than or equal to about 250. In other non-limiting embodiments, it may be desirable for the nanoparticles to have an aspect ratio of less than about 10.
  • one or more metals are used to functionalize the nanoparticle.
  • they are loaded onto the exfoliated nanoparticle by one of a variety of methods including intercalation, adsorption, or ion exchange.
  • the metal retains its valuble properties, for example in the case of silver its anti-microbial properties, while on the nanoparticle.
  • the term loaded, as used herein, includes complete coverage of the surface of the nanoparticle, or alternatively, only a portion thereof.
  • the metal is selected from Groups 3 to 12 of the Periodic Table of Elements, aluminum, and magnesium.
  • the metal is selected from silver, copper, zinc, manganese, platinum, palladium, gold, calcium, barium, aluminum, iron, and mixtures thereof.
  • the metal is silver.
  • the metal or metals may be selected based on the desired effect to be achieved through use of the composite material.
  • silver may be selected for its known anti-microbial properties.
  • the metal may be loaded onto the nanoparticle via intercalation.
  • silver ions in particular, can be inserted among the various layers of layered nanoclay by positioning in a “hole” to maximize favorable interactions between the positively charged silver ion and the various types of oxygen in the silicate structure.
  • Silver ions have been shown to have anti-microbial properties and Laponite that contains intercalated ionic silver, retains these properties. Intercalation is also possible with other metal ions, such as copper, zinc, manganese, etc.
  • the metal may also be loaded onto the nanoparticle via ion exchange.
  • the surface of Laponite platelets is composed mainly of sodium ions, which exist to balance out the negatively charged oxygen atoms donated by the silicate structure in the layer below.
  • positively charged metal ions are added to a solution of exfoliated Laponite, a fraction of the surface sodium ions are displaced by the added metal cations.
  • the metal may also be loaded onto the nanoparticle by adsorption.
  • certain functional groups such as amine, ammonium, and carboxyl groups are strong binders to the face or edge of a platelet of Laponite.
  • Metal ions can be modified by the addition of these ligands so that they are able to bind strongly to the surface of Laponite.
  • reaction sequence for one example is shown below: 2AgNO 3 +2NaOH ⁇ Ag 2 O+2NaNO 3 +H 2 O Ag 2 O+4NH 3 +H 2 O ⁇ 2Ag(NH 3 ) 2 OH
  • the final product, Ag(NH 3 ) 2 OH is contacted with Laponite, whereby the Ag(NH 3 ) 2 OH binds to the face of the Laponite.
  • a metal ion is reduced to a metal (0) in the presence of a starting material, which is exfoliated to form a nanoparticle. Reduction and exfoliation may take place in sequence (either step happening first) or simultaneously upon contacting of the metal with the starting material/exfoliated nanoparticle. The metal is thereby loaded onto the surface of the exfoliated nanoparticle.
  • the metal is silver, which is loaded onto the nanoparticle via intercalation using the Tollen's reagent.
  • the Tollen's reagent is a known silver species able to undergo reduction by either an aldehyde or ketone to form silver metal (0): +Ag(NH 3 ) 2 OH+glucose ⁇ Ag 0
  • the composite material may in incorporated into a variety of systems, materials and compositions, including liquids, solids, gels, coating compositions, cosmetic and pharmaceutical compositions and the like.
  • the composite material may be incorporated into structures or articles of manufacture such as absorbent articles, wound care articles, soft surfaces, or hard surfaces.
  • Compositions containing the composite material may be solutions or dry materials, that are coated, applied, extruded, sprayed, and so forth as further described below. Such compositions may have end uses in manufacturing, commercial, industrial, personal, or domestic applications.
  • Systems comprising the composite material can be employed to bring about certain, desired benefits, for example improved fluid absorbency, wettability, strike-through, comfort, malodor control, lubricity, anti-inflammatory properties, anti-microbial properties, anti-fungal properties, modification of surface friction, flexibility, transparency, modulus, tensile strength, color enhancement, viscosity, smoothness, or gel strength.
  • the presence of the composite material in a composition does not affect the desirable properties of the composition, for example transparency. Addition of the composite material to a liquid composition, for instance, will not alter the transparency or color of the resultant composition as compared to the original, liquid material not containing the composite material. Moreover, since nanoparticles possess large surface areas, the composite material will also allow for higher concentrations of metals to be included in the overall formulation, such as in the treatment of infections.
  • compositions of the invention may comprise the composite material and any other ingredients appropriate for the intended use of the compositions.
  • Some compositions of the invention may comprise: (a) the composite material, which may be an effective amount of the composite material; (b) a suitable carrier medium; and (c) optionally one or more adjunct ingredients.
  • the adjunct ingredients may be, for example, surfactants or charged functionalized molecules exhibiting properties selected from the group consisting of hydrophilic, hydrophobic and mixtures thereof associated with at least some of the composite material, or both.
  • an effective amount of composite material described above can be included in compositions useful for coating a variety of soft surfaces in need of treatment.
  • an effective amount of composite material refers to the quantity of composite material necessary to impart the desired benefit to the soft surface.
  • Such effective amounts are readily ascertained by one of ordinary skill in the art and is based on many factors, such as the particular composite material used, the nature of the soft surface whether a liquid or dry (e.g., granular, powder) composition is required, and the like.
  • the composition may be applied to the surface(s) by washing, spraying, dipping, painting, wiping, or by other manner in order to deliver a coating, especially a transparent coating that covers at least about 0.5% of the surface, or any greater percentage of the surface, including but not limited to: at least about 5%, at least about 10%, at least about 30%, at least about 50%, at least about 80%, and at least about 100% of the surface. Accordingly, the coating may be continuous or discontinuous.
  • the viscosity of the coating composition should be such that it will be capable of passing through the nozzle of a spray device. Such viscosities are well known, and are incorporated herein by reference.
  • the composition may be capable of undergoing shear thinning so that it is capable of being sprayed.
  • Suitable carrier mediums for the compositions containing the composite material include liquids, solids and gases.
  • One suitable carrier medium is water, which can be distilled, deionized, or tap water. Water is valuable due to its low cost, availability, safety, and compatibility.
  • the pH of the liquid, in particular water may be adjusted through the addition of acid or base.
  • Aqueous carrier mediums are also easy apply to a substrate and then dried. Though aqueous carrier mediums are more common than dry, nonaqueous mediums, the composition can exist as a dry powder, granule or tablet or encapsulated complex form.
  • the carrier medium can comprise a low molecular weight organic solvent.
  • the solvent is highly soluble in water, e.g., ethanol, methanol, propanol, isopropanol, ethylene glycol, acetone, and the like, and mixtures thereof.
  • the solvent can be used at any suitable level. Several non-limiting examples, include a level of up to about 50%, or more; from about 0.1% to about 25%; from about 2% to about 15%, and from about 5% to about 10%, by weight of the total composition. Factors to consider when a high level of solvent is used in the composition are odor, flammability, dispersancy of the nanoparticles and environmental impact.
  • the carrier medium may also comprise a film former, which when dried, forms a continuous film.
  • film formers are polyvinyl alcohol, polyethylene oxide, polypropylene oxide, acrylic emulsions, hydroxypropylmethyl cellulose.
  • Adjunct ingredients that may be used in compositions containing the composite material include polymers and copolymers with at least one segment or group which comprises functionality that serves to anchor the composite material to a substrate. These polymers may also comprise at least one segment or group that serves to provide additional character to the polymer, such as hydrophilic or hydrophobic properties.
  • anchoring segments or groups examples include: polyamines, quaternized polyamines, amino groups, quaternized amino groups, and corresponding amine oxides; zwitterionic polymers; polycarboxylates; polyethers; polyhydroxylated polymers; polyphosphonates and polyphosphates; and polymeric chelants.
  • hydrophilizing segments or groups include: ethoxylated or alkoxylated polyamines; polyamines; polycarboxylated polyamines; water soluble polyethers; water soluble polyhydroxylated groups or polymers, including saccharides and polysaccharides; water soluble carboxylates and polycarboxylates; water soluble anionic groups such as carboxylates, sulfonates, sulfates, phosphates, phosphonates and polymers thereof; water soluble amines, quaternaries, amine oxides and polymers thereof; water soluble zwitterionic groups and polymers thereof; water soluble amides and polyamides; and water soluble polymers and copolymers of vinylimidazole and vinylpyrrolidone.
  • hydrophobizing segments or groups include: alkyl, alkylene, and aryl groups, and polymeric aliphatic or aromatic hydrocarbons; fluorocarbons and polymers comprising fluorocarbons; silicones; hydrophobic polyethers such as poly(styrene oxide), poly(propylene oxide), poly(butylene oxide), poly(tetramethylene oxide), and poly(dodecyl glycidyl ether); and hydrophobic polyesters such as polycaprolactone and poly(3-hydroxycarboxylic acids).
  • hydrophilic surface polymers that may be incorporated into the compositions of the invention include, but are not limited to: ethoxylated or alkoxylated polyamines; polycarboxylated polyamines; polycarboxylates including but not limited to polyacrylate; polyethers; polyhydroxyl materials; polyphosphates and phosphonates.
  • hydrophobic surface polymers that may be incorporated into the compositions of the invention include alkylated polyamines include, but are not limited to: polyethyleneimine alkylated with fatty alkylating agents such as dodecyl bromide, octadecyl bromide, oleyl chloride, dodecyl glycidyl ether and benzyl chloride or mixtures thereof; and polyethyleneimine acylated with fatty acylating agents such as methyl dodecanoate and oleoyl chloride; silicones including, but not limited to: polydimethylsiloxane having pendant aminopropyl or aminoethylaminopropyl groups and fluorinated polymers including, but not limited to: polymers including as monomers (meth)acrylate esters of perfluorinated or highly fluorinated alkyl groups.
  • fatty alkylating agents such as dodecyl bromide, octadecyl bromid
  • Non-polymeric surface modifying materials that may be used as adjunct ingredients include fatty amines and quaternized amines including: ditallowdimethylammonium chloride; octadecyltrimethylammonium bromide; dioleyl amine; and benzyltetradecyldimethylammonium chloride. Silicone-based surfactants, fatty zwitterionic surfactants and fatty amine oxides may also be incorporated into the composition.
  • Surfactants are also optional adjunct ingredients. Surfactants are especially useful in the composition as wetting agents to facilitate the dispersion.
  • Suitable surfactants can be selected from the group including anionic surfactants, cationic surfactants, nonionic surfactants, amphoteric surfactants, ampholytic surfactants, zwitterionic surfactants and mixtures thereof.
  • suitable nonionic, anionic, cationic, ampholytic, zwitterionic and semi-polar nonionic surfactants are disclosed in U.S. Pat. Nos. 5,707,950 and 5,576,282.
  • Nonionic surfactants may be characterized by an HLB (hydrophilic-lipophilic balance) of from 5 to 20, alternatively from 6 to 15.
  • silicone surfactants and/or silicones. They can be used alone and/or alternatively in combination with other surfactants described herein above.
  • Nonlimiting examples of silicone surfactants are the polyalkylene oxide polysiloxanes having a dimethyl polysiloxane hydrophobic moiety and one or more hydrophilic polyalkylene side chains
  • the surfactant is should be formulated to be compatible with the composite material, carrier medium and other adjunct ingredients present in the composition.
  • compositions can contain other adjunct ingredients, including but not limited to alkalinity sources, antioxidants, anti-static agents, chelating agents, aminocarboxylate chelators, metallic salts, photoactive inorganic metal oxides, odor-controlling materials, perfumes, photoactivators, polymers, preservatives, processing aids, pigments, and pH control agents, solubilizing agents, zeolites, and mixtures thereof.
  • adjunct ingredients including but not limited to alkalinity sources, antioxidants, anti-static agents, chelating agents, aminocarboxylate chelators, metallic salts, photoactive inorganic metal oxides, odor-controlling materials, perfumes, photoactivators, polymers, preservatives, processing aids, pigments, and pH control agents, solubilizing agents, zeolites, and mixtures thereof.
  • adjunct ingredients including but not limited to alkalinity sources, antioxidants, anti-static agents, chelating agents, aminocarboxylate chelators, metallic salts, photoactive inorganic metal oxides,
  • Coating compositions comprising the composite material can be used on all types of soft surfaces, including but not limited to woven fibers, nonwoven fibers, leather, plastic (for example, toothbrush handles, synthetic film, filaments, toothbrush bristles), and mixtures thereof.
  • the soft surfaces of interest herein may comprise any known type of soft surface, including but not limited to those associated with disposable absorbent articles including but not limited to covers or topsheets, absorbent cores, transfer layers, absorbent inserts, and backsheets including those outer layers made from breathable and nonbreathable films.
  • such a coating composition can be applied to hard surfaces, and provide benefits thereto.
  • the soft surface may comprise one or more fibers.
  • a fiber is defined as a fine hairlike structure, of vegetable, mineral, or synthetic origin. Commercially available fibers have diameters ranging from less than about 0.001 mm (about 0.00004 in) to more than about 0.2 mm (about 0.008 in) and they come in several different forms: short fibers (known as staple, or chopped), continuous single fibers (filaments or monofilaments), untwisted bundles of continuous filaments (tow), and twisted bundles of continuous filaments (yarn). Fibers are classified according to their origin, chemical structure, or both.
  • They can be braided into ropes and cordage, made into felts (also called nonwovens or nonwoven fabrics), woven or knitted into textile fabrics, or, in the case of high-strength fibers, used as reinforcements in composites-that is, products made of two or more different materials.
  • the soft surfaces may comprise fibers made by nature (natural fibers), made by man (synthetic or man-made), or combinations thereof.
  • natural fibers include but are not limited to: animal fibers such as wool, silk, fur, and hair; vegetable fibers such as cellulose, cotton, flax, linen, and hemp; and certain naturally occurring mineral fibers.
  • Synthetic fibers can be derived from natural fibers or not. Examples of synthetic fibers which are derived from natural fibers include but are not limited to rayon and lyocell, both of which are derived from cellulose, a natural polysaccharide fiber. Synthetic fibers which are not derived from natural fibers can be derived from other natural sources or from mineral sources.
  • Example synthetic fibers derived from natural sources include but are not limited to polysaccharides such as starch.
  • Example fibers from mineral sources include but are not limited to polyolefin fibers such as polypropylene and polyethylene fibers, which are derived from petroleum, and silicate fibers such as glass and asbestos.
  • Synthetic fibers are commonly formed, when possible, by fluid handling processes (e.g., extruding, drawing, or spinning a fluid such as a resin or a solution). Synthetic fibers are also formed by solid handling size reduction processes (e.g., mechanical chopping or cutting of a larger object such as a monolith, a film, or a fabric).
  • Disposable absorbent articles such as pantiliners, sanitary napkins, interlabial devices, adult incontinent devices, breast pads, shoe insoles, bandages, and diapers typically are made from absorbent, nonwoven materials (including fibers) and are well known in the art. These articles typically have a fluid permeable body-facing side and fluid impermeable garment facing side. Additionally, such articles may include an absorbent core for retaining fluids therebetween. Addition of the composite material to an article of manufacture such as the absorbent core of a disposable, absorbent article may help control malodor formation and increase absorbency.
  • composite material examples include but are not limited to use in dental abrasives for toothpaste, odor absorbents, and oral rinses.
  • Other uses for the composite material include ophthalmic solutions and devices such as contact lenses.
  • compositions comprising the composite material.
  • These may be in the form of creams, lotions, gels, foams, oils, ointments, or powders for application to tissues including skin, hair, nails, and mucosa such as vaginal or oral mucosa.
  • Such compositions may be formulated as either leave-on products or rinse-off products.
  • such compositions may also be in the form of ophthalmic solutions or ointments, which are applied directly to the eye.
  • the composition contains an anti-acne agent such as salicylic acid or benzoyl peroxide.
  • an anti-acne agent such as salicylic acid or benzoyl peroxide.
  • the composition is a personal lubricant such as those disclosed in U.S. Ser. Nos. 10/137,509; 10/390,511; and 10/389,871, filed May 1, 2002; Mar. 17, 2003; Mar. 17, 2003, respectively.
  • These applications describe warming lubricant compositions that are non-toxic and non-irritating and that can be used as personal lubricants designed to come into contact with the skin or mucosa. When mixed with water, such compositions increase in temperature or generate warmth. This has a soothing effect on the tissues to which these compositions are applied.
  • These compositions are preferably substantially anhydrous and preferably contain at least one polyhydric alcohol.
  • Cosmetic and pharmaceutical compositions may contain a variety of active agents known in the art such as skin lightening agents, skin pigmentation darkening agents, anti-acne agents, sebum modulators, shine control agents, anti-microbial agents, anti-fungals, anti-inflammatory agents, anti-mycotic agents, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants, keratolytic agents, detergents, surfactants, moisturizers, nutrients, vitamins, energy enhancers, anti-perspiration agents, astringents, deodorants, hair removers, firming agents, anti-callous agents, and agents for hair, nail, or skin conditioning.
  • active agents such as skin lightening agents, skin pigmentation darkening agents, anti-acne agents, sebum modulators, shine control agents, anti-microbial agents, anti-fungals, anti-inflammatory agents, anti-mycotic agents, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants,
  • Formulations for topical or mucosal application are well known in the art. Excipients used by those skilled in the art in such formulations may be used with the composite material herein, provided they are compatible.
  • compositions of the present invention can be applied to a surface and optionally allowed to dry on the surface, optionally repeating the application and drying steps as needed. In some embodiments of the methods described herein, including, but not limited to when applying more than one coating, it is not necessarily required to dry the coating(s) between applications.
  • silver ions were reduced in the presence of Laponite using the Tollen's reagent, which is able to undergo reduction by either an aldehyde or ketone to form silver metal via the following reaction: Ag(NH 3 ) 2 OH+glucose ⁇ Ag 0
  • the Tollen's reagent was prepared by adding two drops of 10% NaOH to 5 mL of 5% AgNO 3 to form a gray-brown precipitate. This precipitate was then dissolved by the dropwise addition of 2% NH 4 OH to yield a total Tollen's reagent volume of 30 mL.
  • a solution of silver-loaded Laponite XLS was prepared by adding 600 mg of Laponite XLS to 50 mL of distilled water and using a magnetic stirrer to exfoliate for 20 minutes. To this solution, 800 mg of glucose were added and the stirring continued for 10 minutes to ensure complete dissolution of the glucose. To this, 10 mL of Tollen's reagent as prepared above were added. After two hours of continuous stirring, the solution turned golden yellow in color. Further reaction time yielded a dark amber-brown solution. Samples prepared for particle size analysis and TEM analysis were diluted by a factor of 10 to prevent particle aggregation. The particle size of the nanoparticles dictates the color of the solution caused by a surface plasmon resonance phenomenon. For silver particles, a yellow color has been determined to have the smallest particle size possible. The particle size distribution of the resulting nanoparticles is shown in FIG. 1 .
  • Nanoparticles of silver-laponite were prepared by reduction with sodium citrate, although the reduction by this method was more difficult to control.
  • Citric acid was added to an exfoliated Laponite XLS solution, followed by the addition of silver nitrate. 10% NaOH was added dropwise to form the sodium salt of citric acid until the solution turned faintly yellow. In many cases, the over-addition of sodium hydroxide caused the silver particles to fall out of solution.
  • Nanoparticles of silver-loaded Laponite XLS can be prepared by hydrazine reduction as follows: 5 g of Laponite XLS are added to 995 g of deionized water and stirred for 20 minutes to exfoliate the Laponite XLS. 20 mg of 55% hydrazine hydrate is added to the Laponite XLS dispersion and the solution is stirred for 1 minute. 77 mg of AgNO 3 is dissolved in deionized water. The AgNO 3 solution is added dropwise to the Laponite—hydrazine solution to form a golden-yellow solution containing 0.005% silver-loaded Laponite XLS.
  • Another solution of silver-loaded Laponite XLS was prepared similarly to Example 1, but the order of the components was altered. Glucose and Tollen's reagent were mixed in a separate vessel and once the color of the solution turned faintly gray, this mixture was added to the solution of exfoliated Laponite XLS. After a short period of stirring, the solution turned amber-yellow. This solution was diluted by a factor of 10 for particle size analysis. The particle size distribution of the resulting material is shown in FIG. 2 .
  • a sample was prepared by adding 200 mg of Laponite XLS to 100 mL of water and stirring to exfoliate. The sample was analyzed for particle size. The results are shown in FIG. 3 .
  • Example 6 The sample of Example 6 was diluted by a factor of 50. The sample was analyzed for particle size. The results are shown in FIG. 4 .
  • Examples 1-7 indicate that as a solution of Laponite XLS in water is diluted, the distribution of particle sizes changes.
  • the particle size of silver-loaded Laponite XLS was smaller, on average, than Laponite XLS alone, indicating that the addition of silver to the solution aided in the Laponite XLS exfoliation process.
  • Example 1 shows a single particle size distribution, averaging 4.1 nm in size.
  • Example 5 showed a bimodal particle size distribution with the averages centered on 4.1 nm and 11 nm. This indicates the formation of two different types of particles. It is possible that this solution contained silver-loaded Laponite XLS and colloidal silver with no Laponite core.
  • Example 1 To verify that the Laponite XLS was being coated with silver, TEM (transmission electron microscopic) images and EDX (Energy Dispersive X-Ray) analysis were performed on Examples 1 and 6. The data confirmed that the composite material of Example 1 contained silver-loaded Laponite XLS particles, as opposed to a mixture of colloidal silver and Laponite XLS. Elemental analysis showed the presence of Na, Mg, Si, and Ag (Cu was present in the TEM grid). The data also revealed that particles of very small size ( ⁇ 1 nm), determined to be uncoated Laponite XLS, were also present.
  • a solution containing silver-loaded Laponite XLS particles was prepared as follows. 4.51 g of Laponite XLS was added to 900 mL of deionized water. The solution was stirred for 1 hour and labeled Solution A. To 400 mL of Solution A, 15 mg of NaBH 4 was added. This solution was labeled Solution B. 124 mg of AgNO 3 was dissolved in 5 mL of deionized water; and this was added dropwise to Solution B to form an amber brown solution of 0.02% silver loaded onto Laponite XLS. Following the above procedure, 0.01 %, 0.005% and 0.0025% silver loaded Laponite XLS solutions were prepared.

Abstract

Composite materials comprising nanoparticles functionalized with metals are disclosed. The composite materials may be used in a variety of applications, including in coating compositions, cosmetic and pharmaceutical compositions, absorbent articles, and the like.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application claims priority from U.S. provisional application Ser. No. 60/515,758 filed Oct. 30, 2003.
  • FIELD OF THE INVENTION
  • The present invention relates to composite materials that are functionalized nanoparticles and in particular, metal-loaded nanoclays. Additionally, the present invention relates to a method of forming such composite materials.
  • BACKGROUND OF THE INVENTION
  • For centuries, silver metal has been known to be an agent capable of killing many different microbial species. It was commonly used to purify drinking solutions or administered to sick individuals before the existence of modern antibiotics. Even after the discovery of penicillin and its descendents, colloidal silver solutions were often used in cases in which troublesome bacteria had become resistant to antibiotics.
  • Colloidal silver solutions are commercially available today. They are often unstable, however, and have a short shelf life. This is due to the tendency of the silver particles to aggregate and form clusters so large that they are no longer suspended in solution. For this reason, undesirable gelling agents are added to solutions to keep the silver particles suspended by preventing particle aggregation. Another problem of the commercially available solutions is that the majority of the silver content is usually found to be silver ions. This poses a large problem in medical applications where silver ions rapidly combine with ubiquitous chloride to form an insoluble white precipitate.
  • Nanoparticles have been known to be used as fillers as disclosed in U.S. Pat. No. 6,492,453, as coatings as disclosed in U.S. 2003/0185964 and as foam components as disclosed in U.S. Pat. No. 6,518,324.
  • Nanoparticle systems are disclosed in U.S. 2002/0150678 as being used in a composition and a method to impart surface modifying benefits to soft and hard surfaces. In particular, this application discloses a soft surface coating for articles such as fabrics and garments.
  • Inorganic particulates, such as, clays, silicates, and alumina have been widely used in combination with adjunct detergent and laundry compounds to impart some form of antistatic control and/or fabric softening benefit.
  • The present invention relates to composite materials comprising metal loaded onto exfoliated nanoparticles. Such functionalized nanoparticles may be incorporated into solid and liquid materials to enhance or modify their bulk physical and performance characteristics. In one embodiment, the metal is silver and the nanoparticle comprises a nanoclay. Silver ion is reduced to its neutral metal state (Ag0) and loaded onto the nanoclay. Silver-coated nanoclays in particular have excellent antimicrobial properties, and represent a less expensive alternative to the use of colloidal silver solutions. Such nanoparticles made according to the invention are stable and use less silver metal to generate the same surface area as solid silver particles, making them more cost efficient.
  • SUMMARY OF THE INVENTION
  • The invention provides a composite material comprising (a) an exfoliated nanoparticle having a surface and (b) a metal selected from Groups 3 to 12, aluminum and magnesium, wherein the metal is loaded onto the surface of the nanoparticle.
  • The invention also provides a method of making a composite material comprising an exfoliated nanoparticle having a metal coating, which method comprises: (a) reducing a metal ion to metal; (b) exfoliating a starting material to form a nanoparticle; and (c) contacting the metal with the exfoliated nanoparticle, whereby steps (a) and (b) may be performed sequentially in any order or simultaneously and the metal is loaded onto the surface of the exfoliated nanoparticle.
  • The invention further provides solutions, solids, gels, coating compositions, cosmetic and pharmaceutical compositions, and articles of manufacture comprising such a composite material.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows the particle size distribution of the material of Example 1.
  • FIG. 2 shows the particle size distribution of the material of Example 5.
  • FIG. 3 shows the particle size distribution of the material of Example 6.
  • FIG. 4 shows the particle size distribution of the material of Example 7.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Every limit given throughout this specification includes every lower or higher limit, as the case may be, as if such lower or higher limit was expressly written herein. Every range given throughout this specification includes every narrower range that falls within such broader range, as if such narrower ranges were all expressly written herein.
  • Nanoparticles as used herein means particles (including but not limited to rod-shaped particles, disc-shaped particles, platelet-shaped particles, tetrahedral-shaped particles), fibers, nanotubes, or any other materials having dimensions on the nano scale. In one embodiment, the nanoparticles have an average particle size of about 1 to about 1000 nanometers, preferably 2 to about 750 nanometers. That is, the nanoparticles have a largest dimension (e.g., a diameter or length) of about 1 to 1000 nm. Nanotubes can include structures up to 1 centimeter long, alternatively with a particle size from about 2 to about 50 nanometers. Nanoparticles have very high surface-to-volume ratios. The nanoparticles may be crystalline or amorphous. A single type of nanoparticle may be used, or mixtures of different types of nanoparticles may be used. If a mixture of nanoparticles is used they may be homogeneously or non-homogeneously distributed in the composite material or a system or composition containing the composite material.
  • Non-limiting examples of suitable particle size distributions of nanoparticles are those within the range of about 2 nm to less than about 750 nm, alternatively from about 2 nm to less than about 200 nm, and alternatively from about 2 nm to less than about 150 nm. It should also be understood that certain particle size distributions may be useful to provide certain benefits, and other ranges of particle size distributions may be useful to provide other benefits (for instance, color enhancement requires a different particle size range than the other properties). The average particle size of a batch of nanoparticles may differ from the particle size distribution of those nanoparticles. For example, a layered synthetic silicate can have an average particle size of about 25 nanometers while its particle size distribution can generally vary between about 10 nm to about 40 nm. It should be understood that the particle size distributions described herein are for nanoparticles when they are dispersed in an aqueous medium and the average particle size is based on the mean of the particle size distribution.
  • According to the invention, the nanoparticles are exfoliated. In particular, a starting material is exfoliated or disbursed to form the nanoparticles. Such starting material may have an average size of up to about 50 microns (50,000 nanometers).
  • The nanoparticle may comprise for example natural or synthetic nanoclays, including those made from amorphous or structured clays.
  • In one embodiment, the exfoliated nanoparticle is a nanoclay. In a further embodiment, the nanoparticle is a swellable nanoclay or adduct thereof. A swellable nanoclay has weakly bound ions in interlayer positions that may be hydrated or may absorb organic solvents. These swellable nanoclays generally possess a low cationic or anionic charge, i.e. less than about 0.9 units of charge per unit cell.
  • As used herein, “adducts” means oil swellable nanoclays, i.e. those that swell in organic, non-aqueous solvents such as polar and nonpolar solvents. They may be prepared by reacting a water swellable nanoclay with an organic material that binds to the swellable nanoclay. Examples of such binding organic materials include, but are not limited to, a quaternary ammonium compound having the structure:
    R1R2R3R4N+ X-
    wherein
  • R1, R2, R3 and R4 are each independently selected from H, a C1 to C22 alkyl, a C1 to C22 alkenyl, and a C1 to C22 aralkyl, provided that at least one of the R groups is such an alkyl, alkenyl or aralkyl; and
  • X is the water swellable nanoclay.
  • The swellable nanoclay may be amorphous or structured, i.e., including sheets or layers, wherein a combination of such layers is referred to as a lattice structure. Examples of suitable nanoclays having lattice structures include the pyrophillite (dioctahedral) type, the talc (trioctahedral) type, or mixtures thereof. Classes of suitable structured swellable nanoclays include, but are not limited to the smectite nanoclays, sepiolite nanoclays, zeolite nanoclays, palygorskite nanoclays, or mixtures thereof.
  • Examples of amorphous swellable nanoclays include allophone and imogolite.
  • In one embodiment, the nanoparticles are made from a starting material such as Nanomer 1.34TCN (available from Nanocor) having a particle size of 10 to 18 microns (10000-18000 nanometers). In another embodiment, the nanoparticles are made from PGV (also available from Nanocor) having a particle size of 20 to 25 microns. In another embodiment, exfoliated PGV having a particle size range of 1-3 nanometers is used. In other embodiments, Nanomer 1.34TCN and Nanomer 1.30E having a particle size range of 1-9 nanometers is used.
  • Boehmite alumina can have an average particle size distribution from 2 to 750 nm.
  • Layered clay minerals can be used as starting materials for the exfoliated nanoparticles. The layered clay minerals suitable for use in the present invention include those in the geological classes of the smectites, the kaolins, the illites, the chlorites, the attapulgites and the mixed layer clays. Typical examples of specific clays belonging to these classes are the smectices, kaolins, illites, chlorites, attapulgites and mixed layer clays. Smectites, for example, include montmorillonite, bentonite, pyrophyllite, hectorite, saponite, sauconite, nontronite, talc, beidellite, volchonskoite, stevensite, and vermiculite. In one embodiment, montmorillonite nanoclay is preferred. See U.S. Pat. No. 5,869,033, which is incorporated by reference herein. Kaolins include kaolinite, dickite, nacrite, antigorite, anauxite, halloysite, indellite and chrysotile. Illites include bravaisite, muscovite, paragonite, phlogopite and biotite. Chlorites include corrensite, penninite, donbassite, sudoite, pennine and clinochlore. Attapulgites include sepiolite and polygorskyte. Mixed layer clays include allevardite and vermiculitebiotite. Variants and isomorphic substitutions of these layered clay minerals offer unique applications.
  • Layered clay minerals may be either naturally occurring or synthetic. For example, natural or synthetic hectorites, montmorillonites and bentonites may be used as the starting material for the nanoparticles.
  • Natural clay minerals typically exist as layered silicate minerals and less frequently as amorphous minerals. A layered silicate mineral has SiO4 tetrahedral sheets arranged into a two-dimensional network structure. A 2:1 type layered silicate mineral has a laminated structure of several to several tens of silicate sheets having a three layered structure in which a magnesium octahedral sheet or an aluminum octahedral sheet is sandwiched between two sheets of silica tetrahedral sheets.
  • A sheet of an expandable layer silicate has a negative electric charge, and the electric charge is neutralized by the existence of alkali metal cations and/or alkaline earth metal cations. Smectite or expandable mica can be dispersed in water to form a sol with thixotropic properties. Further, a complex variant of the smectite type clay can be formed by the reaction with various cationic organic or inorganic compounds. An example of such an organic complex, an organophilic clay in which a dimethyldioctadecyl ammonium ion (a quaternary ammonium ion) is introduced by cation exchange. This has been industrially produced and used as a gellant of a coating.
  • Synthetic nanoclays may be employed in the invention. With appropriate process control, the processes for the production of synthetic nanoclays does indeed yield primary particles that are nanoscale. However, the particles are not usually present in the form of discrete particles, but instead predominantly assume the form of agglomerates due to consolidation of the primary particles. Such agglomerates may reach diameters of several thousand nanometers, such that the desired characteristics associated with the nanoscale nature of the particles cannot be achieved. The particles may be deagglomerated, for example, by grinding as described in EP-A 637,616 or by dispersion in a suitable carrier medium, such as water or water/alcohol and mixtures thereof.
  • Synthetic materials for making suitable nanoclays include layered hydrous silicate, layered hydrous aluminum silicate, fluorosilicate, mica-montmorillonite, hydrotalcite, lithium magnesium silicate and lithium magnesium fluorosilicate. An example of a substituted variant of lithium magnesium silicate is where the hydroxyl group is partially substituted with fluorine. Lithium and magnesium may also be partially substituted by aluminum. Lithium magnesium silicate may be isomorphically substituted by any member selected from the group consisting of magnesium, aluminum, lithium, iron, chromium, zinc and mixtures thereof.
  • Synthetic hectorite, for example as commercially marketed under the trade name LAPONITE™ by Southern Clay Products, Inc., may be used as a starting material for the nanoparticles. There are many grades or variants and isomorphous substitutions of LAPONITE™ marketed. Examples of commercial hectorites are LAPONITE B™, LAPONITE S™, LAPONITE XLS™, LAPONITE RD™, LAPONITE XLG™, and LAPONITE RDS™.
  • Synthetic hectorites do not contain any fluorine. An isomorphous substitution of the hydroxyl group with fluorine will produce synthetic clays referred to as sodium magnesium lithium fluorosilicates, which may also be used as the starting material. These sodium magnesium lithium fluorosilicates, marketed as LAPONITE™ and LAPONITE S™, may contain fluoride ions of up to approximately 10% by weight. The fluoride ion content useful in the compositions described herein is up to about 10 or more percent. LAPONITE B™, a sodium magnesium lithium fluorosilicate, has a flat, circular, plate-like shape, with an average particle size, depending on fluoride ion content, of about 25-100 nanometers. For example, in one non-limiting embodiment, LAPONITE B™ having a diameter of about 25-40 nmand and thinkness of about 1 nm may be used. Another variant, called LAPONITE S™, contains about 6% of tetrasodium pyrophosphate as an additive.
  • In one embodiment, Laponite XLS™ is used as the starting material for the nanoparticle, and silver is loaded thereon as the metal. Laponite XLS has tetrahedral silicate layers joined by octahedral magnesium and lithium hydroxyl bridges. This structure allows for exfoliation and modification by either intercalation or adsorption of metal to the nanoclay surface. In the case of intercalation, the metal is inserted between the layers of nanoclay. In the case of surface adsorption, the metal binds to the surface of the nanoclay. Laponite XLS is advantageous because it is synthetically consistent and pure, and exfoliates to form nanoparticles with minimal effort. The surface of the nanoparticle is covered with sodium ions to balance out the negative charge of the many silicate groups.
  • The aspect ratio of the exfoliated nanoparticles, in some cases, is of interest in forming films comprising the composite material with desired characteristics. The aspect ratio of dispersions can be adequately characterized by TEM (transmission electron microscopy).
  • The aspect ratio of nanoparticles in one embodiment can be in the range of 100 to 250. In another embodiment, the aspect ratio of the nanoparticles is 200 to 350.
  • For example, the average aspect ratio of individual particles of LAPONITE B™ is approximately 20-40 and the average aspect ratio of individual particles of LAPONITE RD™ is approximately 10-15. LAPONITE B™ occurs in dispersions as essentially single clay particles or stacks of two clay particles. LAPONITE RD™ occurs essentially as stacks of two or more single clay particles.
  • In some embodiments, a high aspect ratio may be desirable for film formation. The aspect ratio of exfoliated nanoparticles dispersed in a suitable carrier medium, such as water, is also of interest. The aspect ratio of the nanoparticles in a dispersed medium is lower where several of the particles are aggregated.
  • In certain embodiments, it may be desirable for at least some individual (non-aggregated) platelet and disc-shaped nanoparticles to have at least one dimension that is greater than or equal to about 0.5 nm, and an aspect ratio of greater than or equal to about 15. Larger aspect ratios may be more desirable for platelet and disc-shaped nanoparticles than for rod-shaped nanoparticles.
  • The aspect ratio of rod-shaped nanoparticles can be lower than that of disc-shaped or platelet-shaped nanoparticles while maintaining adequate film-forming properties. In certain non-limiting embodiments, it may be desirable for at least some of the individual rod-shaped nanoparticles to have at least one dimension that is greater than or equal to about 0.5 nm, and an aspect ratio of greater than or equal to about 3.
  • The aspect ratio of spheroid-shaped nanoparticles is generally less than or equal to about 5. Nanoparticles preferred for the embodiments presented here have aspect ratios of less than or equal to about 250. In other non-limiting embodiments, it may be desirable for the nanoparticles to have an aspect ratio of less than about 10.
  • According to the invention, one or more metals are used to functionalize the nanoparticle. In particular, they are loaded onto the exfoliated nanoparticle by one of a variety of methods including intercalation, adsorption, or ion exchange. Advantageously, the metal retains its valuble properties, for example in the case of silver its anti-microbial properties, while on the nanoparticle. The term loaded, as used herein, includes complete coverage of the surface of the nanoparticle, or alternatively, only a portion thereof.
  • In one embodiment, the metal is selected from Groups 3 to 12 of the Periodic Table of Elements, aluminum, and magnesium. Preferably, the metal is selected from silver, copper, zinc, manganese, platinum, palladium, gold, calcium, barium, aluminum, iron, and mixtures thereof. In a particularly preferred embodiment, the metal is silver.
  • The metal or metals may be selected based on the desired effect to be achieved through use of the composite material. For example, silver may be selected for its known anti-microbial properties.
  • The metal may be loaded onto the nanoparticle via intercalation. For example, silver ions, in particular, can be inserted among the various layers of layered nanoclay by positioning in a “hole” to maximize favorable interactions between the positively charged silver ion and the various types of oxygen in the silicate structure. Silver ions have been shown to have anti-microbial properties and Laponite that contains intercalated ionic silver, retains these properties. Intercalation is also possible with other metal ions, such as copper, zinc, manganese, etc.
  • The metal may also be loaded onto the nanoparticle via ion exchange. For example, the surface of Laponite platelets is composed mainly of sodium ions, which exist to balance out the negatively charged oxygen atoms donated by the silicate structure in the layer below. When positively charged metal ions are added to a solution of exfoliated Laponite, a fraction of the surface sodium ions are displaced by the added metal cations.
  • The metal may also be loaded onto the nanoparticle by adsorption. For example, certain functional groups such as amine, ammonium, and carboxyl groups are strong binders to the face or edge of a platelet of Laponite. Metal ions can be modified by the addition of these ligands so that they are able to bind strongly to the surface of Laponite. The reaction sequence for one example is shown below:
    2AgNO3+2NaOH→Ag2O+2NaNO3+H2O
    Ag2O+4NH3+H2O→2Ag(NH3)2OH
    The final product, Ag(NH3)2OH, is contacted with Laponite, whereby the Ag(NH3)2OH binds to the face of the Laponite.
  • In one embodiment of the invention a metal ion is reduced to a metal (0) in the presence of a starting material, which is exfoliated to form a nanoparticle. Reduction and exfoliation may take place in sequence (either step happening first) or simultaneously upon contacting of the metal with the starting material/exfoliated nanoparticle. The metal is thereby loaded onto the surface of the exfoliated nanoparticle.
  • In one embodiment of the invention, the metal is silver, which is loaded onto the nanoparticle via intercalation using the Tollen's reagent. The Tollen's reagent is a known silver species able to undergo reduction by either an aldehyde or ketone to form silver metal (0):
    +Ag(NH3)2OH+glucose→Ag0
  • The composite material may in incorporated into a variety of systems, materials and compositions, including liquids, solids, gels, coating compositions, cosmetic and pharmaceutical compositions and the like. The composite material may be incorporated into structures or articles of manufacture such as absorbent articles, wound care articles, soft surfaces, or hard surfaces. Compositions containing the composite material may be solutions or dry materials, that are coated, applied, extruded, sprayed, and so forth as further described below. Such compositions may have end uses in manufacturing, commercial, industrial, personal, or domestic applications.
  • Systems comprising the composite material can be employed to bring about certain, desired benefits, for example improved fluid absorbency, wettability, strike-through, comfort, malodor control, lubricity, anti-inflammatory properties, anti-microbial properties, anti-fungal properties, modification of surface friction, flexibility, transparency, modulus, tensile strength, color enhancement, viscosity, smoothness, or gel strength.
  • In certain embodiments, the presence of the composite material in a composition does not affect the desirable properties of the composition, for example transparency. Addition of the composite material to a liquid composition, for instance, will not alter the transparency or color of the resultant composition as compared to the original, liquid material not containing the composite material. Moreover, since nanoparticles possess large surface areas, the composite material will also allow for higher concentrations of metals to be included in the overall formulation, such as in the treatment of infections.
  • Compositions of the invention may comprise the composite material and any other ingredients appropriate for the intended use of the compositions. Some compositions of the invention may comprise: (a) the composite material, which may be an effective amount of the composite material; (b) a suitable carrier medium; and (c) optionally one or more adjunct ingredients. The adjunct ingredients may be, for example, surfactants or charged functionalized molecules exhibiting properties selected from the group consisting of hydrophilic, hydrophobic and mixtures thereof associated with at least some of the composite material, or both.
  • Alternatively, an effective amount of composite material described above can be included in compositions useful for coating a variety of soft surfaces in need of treatment. As used herein, an effective amount of composite material refers to the quantity of composite material necessary to impart the desired benefit to the soft surface. Such effective amounts are readily ascertained by one of ordinary skill in the art and is based on many factors, such as the particular composite material used, the nature of the soft surface whether a liquid or dry (e.g., granular, powder) composition is required, and the like.
  • The composition may be applied to the surface(s) by washing, spraying, dipping, painting, wiping, or by other manner in order to deliver a coating, especially a transparent coating that covers at least about 0.5% of the surface, or any greater percentage of the surface, including but not limited to: at least about 5%, at least about 10%, at least about 30%, at least about 50%, at least about 80%, and at least about 100% of the surface. Accordingly, the coating may be continuous or discontinuous.
  • If the coating composition is to be sprayed onto the surface, the viscosity of the coating composition should be such that it will be capable of passing through the nozzle of a spray device. Such viscosities are well known, and are incorporated herein by reference. The composition may be capable of undergoing shear thinning so that it is capable of being sprayed.
  • Suitable carrier mediums for the compositions containing the composite material include liquids, solids and gases. One suitable carrier medium is water, which can be distilled, deionized, or tap water. Water is valuable due to its low cost, availability, safety, and compatibility. The pH of the liquid, in particular water, may be adjusted through the addition of acid or base. Aqueous carrier mediums are also easy apply to a substrate and then dried. Though aqueous carrier mediums are more common than dry, nonaqueous mediums, the composition can exist as a dry powder, granule or tablet or encapsulated complex form.
  • Optionally, in addition to or in place of water, the carrier medium can comprise a low molecular weight organic solvent. Preferably, the solvent is highly soluble in water, e.g., ethanol, methanol, propanol, isopropanol, ethylene glycol, acetone, and the like, and mixtures thereof. The solvent can be used at any suitable level. Several non-limiting examples, include a level of up to about 50%, or more; from about 0.1% to about 25%; from about 2% to about 15%, and from about 5% to about 10%, by weight of the total composition. Factors to consider when a high level of solvent is used in the composition are odor, flammability, dispersancy of the nanoparticles and environmental impact.
  • The carrier medium may also comprise a film former, which when dried, forms a continuous film. Examples of film formers are polyvinyl alcohol, polyethylene oxide, polypropylene oxide, acrylic emulsions, hydroxypropylmethyl cellulose.
  • Adjunct ingredients that may be used in compositions containing the composite material include polymers and copolymers with at least one segment or group which comprises functionality that serves to anchor the composite material to a substrate. These polymers may also comprise at least one segment or group that serves to provide additional character to the polymer, such as hydrophilic or hydrophobic properties.
  • Examples of the anchoring segments or groups include: polyamines, quaternized polyamines, amino groups, quaternized amino groups, and corresponding amine oxides; zwitterionic polymers; polycarboxylates; polyethers; polyhydroxylated polymers; polyphosphonates and polyphosphates; and polymeric chelants.
  • Examples of the hydrophilizing segments or groups include: ethoxylated or alkoxylated polyamines; polyamines; polycarboxylated polyamines; water soluble polyethers; water soluble polyhydroxylated groups or polymers, including saccharides and polysaccharides; water soluble carboxylates and polycarboxylates; water soluble anionic groups such as carboxylates, sulfonates, sulfates, phosphates, phosphonates and polymers thereof; water soluble amines, quaternaries, amine oxides and polymers thereof; water soluble zwitterionic groups and polymers thereof; water soluble amides and polyamides; and water soluble polymers and copolymers of vinylimidazole and vinylpyrrolidone.
  • Examples of the hydrophobizing segments or groups include: alkyl, alkylene, and aryl groups, and polymeric aliphatic or aromatic hydrocarbons; fluorocarbons and polymers comprising fluorocarbons; silicones; hydrophobic polyethers such as poly(styrene oxide), poly(propylene oxide), poly(butylene oxide), poly(tetramethylene oxide), and poly(dodecyl glycidyl ether); and hydrophobic polyesters such as polycaprolactone and poly(3-hydroxycarboxylic acids).
  • Examples of hydrophilic surface polymers that may be incorporated into the compositions of the invention include, but are not limited to: ethoxylated or alkoxylated polyamines; polycarboxylated polyamines; polycarboxylates including but not limited to polyacrylate; polyethers; polyhydroxyl materials; polyphosphates and phosphonates.
  • Examples of hydrophobic surface polymers that may be incorporated into the compositions of the invention include alkylated polyamines include, but are not limited to: polyethyleneimine alkylated with fatty alkylating agents such as dodecyl bromide, octadecyl bromide, oleyl chloride, dodecyl glycidyl ether and benzyl chloride or mixtures thereof; and polyethyleneimine acylated with fatty acylating agents such as methyl dodecanoate and oleoyl chloride; silicones including, but not limited to: polydimethylsiloxane having pendant aminopropyl or aminoethylaminopropyl groups and fluorinated polymers including, but not limited to: polymers including as monomers (meth)acrylate esters of perfluorinated or highly fluorinated alkyl groups.
  • Non-polymeric surface modifying materials that may be used as adjunct ingredients include fatty amines and quaternized amines including: ditallowdimethylammonium chloride; octadecyltrimethylammonium bromide; dioleyl amine; and benzyltetradecyldimethylammonium chloride. Silicone-based surfactants, fatty zwitterionic surfactants and fatty amine oxides may also be incorporated into the composition.
  • Surfactants are also optional adjunct ingredients. Surfactants are especially useful in the composition as wetting agents to facilitate the dispersion.
  • Suitable surfactants can be selected from the group including anionic surfactants, cationic surfactants, nonionic surfactants, amphoteric surfactants, ampholytic surfactants, zwitterionic surfactants and mixtures thereof. Examples of suitable nonionic, anionic, cationic, ampholytic, zwitterionic and semi-polar nonionic surfactants are disclosed in U.S. Pat. Nos. 5,707,950 and 5,576,282. Nonionic surfactants may be characterized by an HLB (hydrophilic-lipophilic balance) of from 5 to 20, alternatively from 6 to 15.
  • Mixtures of anionic and nonionic surfactants are especially useful. Other conventional useful surfactants are listed in standard texts.
  • Another class of adjunct ingredients that may be useful are silicone surfactants and/or silicones. They can be used alone and/or alternatively in combination with other surfactants described herein above. Nonlimiting examples of silicone surfactants are the polyalkylene oxide polysiloxanes having a dimethyl polysiloxane hydrophobic moiety and one or more hydrophilic polyalkylene side chains
  • If used, the surfactant is should be formulated to be compatible with the composite material, carrier medium and other adjunct ingredients present in the composition.
  • The compositions can contain other adjunct ingredients, including but not limited to alkalinity sources, antioxidants, anti-static agents, chelating agents, aminocarboxylate chelators, metallic salts, photoactive inorganic metal oxides, odor-controlling materials, perfumes, photoactivators, polymers, preservatives, processing aids, pigments, and pH control agents, solubilizing agents, zeolites, and mixtures thereof. These optional ingredients may be included at any desired level.
  • Coating compositions comprising the composite material can be used on all types of soft surfaces, including but not limited to woven fibers, nonwoven fibers, leather, plastic (for example, toothbrush handles, synthetic film, filaments, toothbrush bristles), and mixtures thereof. The soft surfaces of interest herein may comprise any known type of soft surface, including but not limited to those associated with disposable absorbent articles including but not limited to covers or topsheets, absorbent cores, transfer layers, absorbent inserts, and backsheets including those outer layers made from breathable and nonbreathable films.
  • It should be understood that in certain embodiments, such a coating composition can be applied to hard surfaces, and provide benefits thereto.
  • In certain embodiments, the soft surface may comprise one or more fibers. A fiber is defined as a fine hairlike structure, of vegetable, mineral, or synthetic origin. Commercially available fibers have diameters ranging from less than about 0.001 mm (about 0.00004 in) to more than about 0.2 mm (about 0.008 in) and they come in several different forms: short fibers (known as staple, or chopped), continuous single fibers (filaments or monofilaments), untwisted bundles of continuous filaments (tow), and twisted bundles of continuous filaments (yarn). Fibers are classified according to their origin, chemical structure, or both. They can be braided into ropes and cordage, made into felts (also called nonwovens or nonwoven fabrics), woven or knitted into textile fabrics, or, in the case of high-strength fibers, used as reinforcements in composites-that is, products made of two or more different materials.
  • The soft surfaces may comprise fibers made by nature (natural fibers), made by man (synthetic or man-made), or combinations thereof. Example of natural fibers include but are not limited to: animal fibers such as wool, silk, fur, and hair; vegetable fibers such as cellulose, cotton, flax, linen, and hemp; and certain naturally occurring mineral fibers. Synthetic fibers can be derived from natural fibers or not. Examples of synthetic fibers which are derived from natural fibers include but are not limited to rayon and lyocell, both of which are derived from cellulose, a natural polysaccharide fiber. Synthetic fibers which are not derived from natural fibers can be derived from other natural sources or from mineral sources. Example synthetic fibers derived from natural sources include but are not limited to polysaccharides such as starch. Example fibers from mineral sources include but are not limited to polyolefin fibers such as polypropylene and polyethylene fibers, which are derived from petroleum, and silicate fibers such as glass and asbestos. Synthetic fibers are commonly formed, when possible, by fluid handling processes (e.g., extruding, drawing, or spinning a fluid such as a resin or a solution). Synthetic fibers are also formed by solid handling size reduction processes (e.g., mechanical chopping or cutting of a larger object such as a monolith, a film, or a fabric).
  • Disposable absorbent articles, such as pantiliners, sanitary napkins, interlabial devices, adult incontinent devices, breast pads, shoe insoles, bandages, and diapers typically are made from absorbent, nonwoven materials (including fibers) and are well known in the art. These articles typically have a fluid permeable body-facing side and fluid impermeable garment facing side. Additionally, such articles may include an absorbent core for retaining fluids therebetween. Addition of the composite material to an article of manufacture such as the absorbent core of a disposable, absorbent article may help control malodor formation and increase absorbency.
  • Other uses for the composite material include but are not limited to use in dental abrasives for toothpaste, odor absorbents, and oral rinses. Other uses for the composite material include ophthalmic solutions and devices such as contact lenses.
  • Another embodiment of the invention relates to cosmetic and pharmaceutical compositions comprising the composite material. These may be in the form of creams, lotions, gels, foams, oils, ointments, or powders for application to tissues including skin, hair, nails, and mucosa such as vaginal or oral mucosa. Such compositions may be formulated as either leave-on products or rinse-off products. Alternatively, such compositions may also be in the form of ophthalmic solutions or ointments, which are applied directly to the eye.
  • In one embodiment, the composition contains an anti-acne agent such as salicylic acid or benzoyl peroxide.
  • In another embodiment, the composition is a personal lubricant such as those disclosed in U.S. Ser. Nos. 10/137,509; 10/390,511; and 10/389,871, filed May 1, 2002; Mar. 17, 2003; Mar. 17, 2003, respectively. These applications describe warming lubricant compositions that are non-toxic and non-irritating and that can be used as personal lubricants designed to come into contact with the skin or mucosa. When mixed with water, such compositions increase in temperature or generate warmth. This has a soothing effect on the tissues to which these compositions are applied. These compositions are preferably substantially anhydrous and preferably contain at least one polyhydric alcohol. By incorporating the composite material into these personal lubrications, the resultant compositions have a smoother characteristic and remain as clear solutions, as the composite material does not detract from the transparency of the compositions.
  • Cosmetic and pharmaceutical compositions may contain a variety of active agents known in the art such as skin lightening agents, skin pigmentation darkening agents, anti-acne agents, sebum modulators, shine control agents, anti-microbial agents, anti-fungals, anti-inflammatory agents, anti-mycotic agents, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants, keratolytic agents, detergents, surfactants, moisturizers, nutrients, vitamins, energy enhancers, anti-perspiration agents, astringents, deodorants, hair removers, firming agents, anti-callous agents, and agents for hair, nail, or skin conditioning.
  • Formulations for topical or mucosal application are well known in the art. Excipients used by those skilled in the art in such formulations may be used with the composite material herein, provided they are compatible.
  • The compositions of the present invention can be applied to a surface and optionally allowed to dry on the surface, optionally repeating the application and drying steps as needed. In some embodiments of the methods described herein, including, but not limited to when applying more than one coating, it is not necessarily required to dry the coating(s) between applications.
  • EXAMPLES Example 1
  • In order to deposit silver metal on nanoclay, silver ions were reduced in the presence of Laponite using the Tollen's reagent, which is able to undergo reduction by either an aldehyde or ketone to form silver metal via the following reaction:
    Ag(NH3)2OH+glucose→Ag0
  • The Tollen's reagent was prepared by adding two drops of 10% NaOH to 5 mL of 5% AgNO3 to form a gray-brown precipitate. This precipitate was then dissolved by the dropwise addition of 2% NH4OH to yield a total Tollen's reagent volume of 30 mL.
  • A solution of silver-loaded Laponite XLS was prepared by adding 600 mg of Laponite XLS to 50 mL of distilled water and using a magnetic stirrer to exfoliate for 20 minutes. To this solution, 800 mg of glucose were added and the stirring continued for 10 minutes to ensure complete dissolution of the glucose. To this, 10 mL of Tollen's reagent as prepared above were added. After two hours of continuous stirring, the solution turned golden yellow in color. Further reaction time yielded a dark amber-brown solution. Samples prepared for particle size analysis and TEM analysis were diluted by a factor of 10 to prevent particle aggregation. The particle size of the nanoparticles dictates the color of the solution caused by a surface plasmon resonance phenomenon. For silver particles, a yellow color has been determined to have the smallest particle size possible. The particle size distribution of the resulting nanoparticles is shown in FIG. 1.
  • Example 2
  • The formation of silver metal from silver ions was also investigated using NaBH4:
    4AgNO3+NaBH4→4Ag0
  • Dropwise addition of 32 mg of AgNO3 dissolved in 5 mL of H2O to a solution containing 500 mg of exfoliated Laponite XLS and 4 mg NaBH4 yielded a golden yellow solution. This addition order for this particular reaction was determined to give the smallest particle size.
  • Example 3
  • Nanoparticles of silver-laponite were prepared by reduction with sodium citrate, although the reduction by this method was more difficult to control. Citric acid was added to an exfoliated Laponite XLS solution, followed by the addition of silver nitrate. 10% NaOH was added dropwise to form the sodium salt of citric acid until the solution turned faintly yellow. In many cases, the over-addition of sodium hydroxide caused the silver particles to fall out of solution.
    AgNO3+sodium citrate→Ag0
  • Example 4
  • Nanoparticles of silver-loaded Laponite XLS can be prepared by hydrazine reduction as follows: 5 g of Laponite XLS are added to 995 g of deionized water and stirred for 20 minutes to exfoliate the Laponite XLS. 20 mg of 55% hydrazine hydrate is added to the Laponite XLS dispersion and the solution is stirred for 1 minute. 77 mg of AgNO3 is dissolved in deionized water. The AgNO3 solution is added dropwise to the Laponite—hydrazine solution to form a golden-yellow solution containing 0.005% silver-loaded Laponite XLS.
  • Example 5
  • Another solution of silver-loaded Laponite XLS was prepared similarly to Example 1, but the order of the components was altered. Glucose and Tollen's reagent were mixed in a separate vessel and once the color of the solution turned faintly gray, this mixture was added to the solution of exfoliated Laponite XLS. After a short period of stirring, the solution turned amber-yellow. This solution was diluted by a factor of 10 for particle size analysis. The particle size distribution of the resulting material is shown in FIG. 2.
  • Example 6
  • A sample was prepared by adding 200 mg of Laponite XLS to 100 mL of water and stirring to exfoliate. The sample was analyzed for particle size. The results are shown in FIG. 3.
  • Example 7
  • The sample of Example 6 was diluted by a factor of 50. The sample was analyzed for particle size. The results are shown in FIG. 4.
  • The results of Examples 1-7 indicate that as a solution of Laponite XLS in water is diluted, the distribution of particle sizes changes. The particle size of silver-loaded Laponite XLS was smaller, on average, than Laponite XLS alone, indicating that the addition of silver to the solution aided in the Laponite XLS exfoliation process.
  • The data for Example 1 shows a single particle size distribution, averaging 4.1 nm in size. Example 5, on the other hand, showed a bimodal particle size distribution with the averages centered on 4.1 nm and 11 nm. This indicates the formation of two different types of particles. It is possible that this solution contained silver-loaded Laponite XLS and colloidal silver with no Laponite core.
  • Example 8
  • To verify that the Laponite XLS was being coated with silver, TEM (transmission electron microscopic) images and EDX (Energy Dispersive X-Ray) analysis were performed on Examples 1 and 6. The data confirmed that the composite material of Example 1 contained silver-loaded Laponite XLS particles, as opposed to a mixture of colloidal silver and Laponite XLS. Elemental analysis showed the presence of Na, Mg, Si, and Ag (Cu was present in the TEM grid). The data also revealed that particles of very small size (≈1 nm), determined to be uncoated Laponite XLS, were also present.
  • Example 9
  • A solution containing silver-loaded Laponite XLS particles was prepared as follows. 4.51 g of Laponite XLS was added to 900 mL of deionized water. The solution was stirred for 1 hour and labeled Solution A. To 400 mL of Solution A, 15 mg of NaBH4 was added. This solution was labeled Solution B. 124 mg of AgNO3 was dissolved in 5 mL of deionized water; and this was added dropwise to Solution B to form an amber brown solution of 0.02% silver loaded onto Laponite XLS. Following the above procedure, 0.01 %, 0.005% and 0.0025% silver loaded Laponite XLS solutions were prepared. These solutions were analyzed for biocidal activity against the organisms Staphylococcus aureus and Escherichia coli as follows. The silver-loaded Laponite XLS solutions were inoculated with the bacteria and neutralized with Letheen Broth containing 1.5% to neutralize the activity after the appropriate time. Aliquots were plated using Letheen Agar. The bacterial log reduction is given in the Table below.
    E.c. - 5
    Sample Conc. S.a. - 5 minute S.a. - 10 min minutes E.c. - 10 min.
    0.0025%  0.8 2.2 3.2 5.3
    0.005%  4.8 4.8 5.3 5.3
    0.01% 2.2 4.8 5.3 5.3
    0.02% 4.8 4.8 5.3 5.3

Claims (23)

1. A composite material comprising (a) an exfoliated nanoparticle having a surface and (b) a metal selected from Groups 3 to 12, aluminum and magnesium, wherein the metal is loaded onto the surface of the nanoparticle.
2. The composite material of claim 1, wherein the metal is loaded onto the surface of the nanoparticle by intercalation.
3. The composite material of claim 1, wherein the metal is loaded onto the surface of the nanoparticle by adsorption.
4. The composite material of claim 1, wherein the metal is loaded onto the surface of the nanoparticle by ion exchange.
5. The composite material of claim 1, wherein the metal is selected from the group consisting of silver, copper, zinc, manganese, platinum, palladium, gold, calcium, barium, aluminum, iron, and mixtures thereof.
6. The composite material of claim 1, wherein the nanoparticle comprises a nanoclay.
7. The composite material of claim 1, wherein the nanoparticle comprises exfoliated Laponite.
8. A solution comprising the composite material of claim 1.
9. A solid comprising the composite material of claim 1.
10. A gel comprising the composite material of claim 1.
11. A composition comprising the composite material of claim 1.
12. The composition of claim 11, further comprising one or more adjunct ingredients and a carrier medium.
13. The composition of claim 12, wherein the adjunct ingredients are selected from surfactants and charged functionalized molecules.
14. The composition of claim 12, wherein the carrier medium comprises is an aqueous carrier medium.
15. A cosmetic or pharmaceutical composition comprising the composite material of claim 1.
16. The composition of claim 15, further comprising an active agent selected from skin lightening agents, skin pigmentation darkening agents, anti-acne agents, sebum modulators, shine control agents, anti-microbial agents, anti-fungals, anti-inflammatory agents, anti-mycotic agents, anti-parasite agents, external analgesics, sunscreens, photoprotectors, antioxidants, keratolytic agents, detergents, surfactants, moisturizers, nutrients, vitamins, energy enhancers, anti-perspiration agents, astringents, deodorants, hair removers, firming agents, anti-callous agents, and agents for hair, nail, or skin conditioning.
17. A method of making a composite material comprising an exfoliated nanoparticle having a metal coating, which method comprises: (a) reducing a metal ion to metal; (b) exfoliating a starting material to form an exfoliated nanoparticle; and (c) contacting the metal with the exfoliated nanoparticle, whereby steps (a) and (b) may be performed sequentially in any order or simultaneously and the metal is loaded onto the surface of the exfoliated nanoparticle.
18. The method of claim 17, wherein the metal is loaded onto the surface of the nanoparticle by intercalation.
19. The method of claim 17, wherein the metal is loaded onto the surface of the nanoparticle by adsorption.
20. The method of claim 17, wherein the metal is loaded onto the surface of the nanoparticle by ion exchange.
21. The method of claim 17, wherein the metal is selected from the group consisting of silver, copper, zinc, manganese, platinum, palladium, gold, calcium, barium, aluminum, iron, and mixtures thereof.
22. The method of claim 17, wherein the nanoparticle comprises a nanoclay.
23. The method of claim 22, wherein the nanoparticle comprises exfoliated Laponite.
US10/979,365 2003-10-30 2004-11-01 Enhancing properties by the use of nanoparticles Abandoned US20050175649A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/979,365 US20050175649A1 (en) 2003-10-30 2004-11-01 Enhancing properties by the use of nanoparticles
US13/792,478 US20130189334A1 (en) 2003-10-30 2013-03-11 Enhancing properties by the use of nanoparticles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51575803P 2003-10-30 2003-10-30
US10/979,365 US20050175649A1 (en) 2003-10-30 2004-11-01 Enhancing properties by the use of nanoparticles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/792,478 Continuation US20130189334A1 (en) 2003-10-30 2013-03-11 Enhancing properties by the use of nanoparticles

Publications (1)

Publication Number Publication Date
US20050175649A1 true US20050175649A1 (en) 2005-08-11

Family

ID=34549441

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/979,365 Abandoned US20050175649A1 (en) 2003-10-30 2004-11-01 Enhancing properties by the use of nanoparticles
US10/979,364 Expired - Fee Related US7988779B2 (en) 2003-10-30 2004-11-01 Absorbent articles comprising nanoparticles
US13/792,478 Abandoned US20130189334A1 (en) 2003-10-30 2013-03-11 Enhancing properties by the use of nanoparticles

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/979,364 Expired - Fee Related US7988779B2 (en) 2003-10-30 2004-11-01 Absorbent articles comprising nanoparticles
US13/792,478 Abandoned US20130189334A1 (en) 2003-10-30 2013-03-11 Enhancing properties by the use of nanoparticles

Country Status (11)

Country Link
US (3) US20050175649A1 (en)
EP (2) EP1677843B1 (en)
JP (2) JP2007519615A (en)
CN (2) CN1925879B (en)
AT (2) ATE405300T1 (en)
AU (2) AU2004285578B2 (en)
BR (2) BRPI0416114A (en)
CA (2) CA2544119C (en)
DE (2) DE602004015134D1 (en)
ES (1) ES2311879T3 (en)
WO (2) WO2005042040A1 (en)

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119689A1 (en) * 2001-09-24 2003-06-26 Hutton Howard David Cleaning composition
US20080058738A1 (en) * 2006-08-31 2008-03-06 Kimberly-Clark Worldwide, Inc. Derivatized expanded starch for odor control
US20080058739A1 (en) * 2006-08-31 2008-03-06 Kimberly-Clark Worldwide, Inc. Expanded starch for odor control
US20080085962A1 (en) * 2006-10-06 2008-04-10 General Electric Company Composition and associated method
US20080085410A1 (en) * 2006-10-06 2008-04-10 General Electric Company Composition and associated method
US20080103459A1 (en) * 2006-10-30 2008-05-01 Anthony Di Salvo Enzyme inhibition using nanoparticles
WO2008068418A2 (en) * 2006-11-15 2008-06-12 Skin'up Textile and/or fiber processing method using an active ingredient composed of nanoparticles<0}
US20080229612A1 (en) * 2007-03-22 2008-09-25 Poshpeds Incorporated Human wearable laminar structure, insole made therefrom and methods for their manufacture
US20080269186A1 (en) * 2006-04-24 2008-10-30 Carlo Alberto Bignozzi Functional Nanomaterials With Antibacterial and Antiviral Activity
US20080306456A1 (en) * 2005-12-14 2008-12-11 Birgit Riesinger Wound Treatment Device with Elastically Deformable Vacuum-Generating Element
WO2009045720A2 (en) 2007-09-28 2009-04-09 Johnson & Johnson Consumer Companies, Inc. Electricity-generating particulates and the use thereof
US20090092836A1 (en) * 2007-10-04 2009-04-09 Gwamgju Institute Of Science And Technology Gold nanoparticle-halloysite nanotube and method of forming the same
US20090104434A1 (en) * 2007-10-17 2009-04-23 Jennifer Hoyt Lalli Conformal multifunctional coatings
US20090148484A1 (en) * 2007-12-07 2009-06-11 National Taiwan University Stably-dispersing composite of metal nanoparticle and inorganic clay and method for producing the same
US20090302280A1 (en) * 2006-10-06 2009-12-10 General Electric Company Composition and associated method
US20100004588A1 (en) * 2008-07-01 2010-01-07 Baxter International Inc. Nanoclay sorbents for dialysis
US20100136325A1 (en) * 2006-11-27 2010-06-03 Reddy Ganta S Antimicrobial materials and coatings
EP2206503A1 (en) * 2007-10-05 2010-07-14 Universidad De Santiago De Compostela Use of atomic quantum clusters (aqc) as antimicrobial agents and biocides
US20100196294A1 (en) * 2007-01-26 2010-08-05 Coty Inc. Coatings for mammalian nails that include nanosized particles
WO2010111511A1 (en) * 2009-03-27 2010-09-30 Johnson & Johnson Consumer Companies, Inc. Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
WO2010111502A2 (en) 2009-03-27 2010-09-30 Ethicon, Inc. Medical devices with galvanic particulates
WO2011035988A1 (en) * 2009-09-24 2011-03-31 Closed Stock Company "Institute Of Applied Nanotechnology" Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application
WO2011035989A3 (en) * 2009-09-24 2011-06-23 Closed Stock Company "Institute Of Applied Nanotechnology" Method of processing a thread especially for medical uses
EP2353578A2 (en) 2010-02-05 2011-08-10 Johnson & Johnson Consumer Companies, Inc. Lip compositions comprising galvanic particulates
WO2011109259A1 (en) 2010-03-01 2011-09-09 Johnson & Johnson Consumer Companies, Inc. Skin care composition having desirable bulk color
WO2011130112A1 (en) 2010-04-16 2011-10-20 Ethicon, Inc. Medical devices with galvanic particulates
WO2011131422A1 (en) * 2010-04-20 2011-10-27 Closed Stock Company "Institute Of Applied Nanotechnology" Toilet soap with antimicrobic properties
WO2011160860A1 (en) * 2010-06-21 2011-12-29 Closed Stock Company "Institute Of Applied Nanotechnology" Compositions for antiseptic processing of woven materials
WO2012006526A2 (en) 2010-07-08 2012-01-12 Johnson & Johnson Consumer Companies, Inc. Skin care emulsion composition
WO2012028340A1 (en) * 2010-08-31 2012-03-08 Closed Stock Company "Institute Of Applied Nanotechnology" Preventive ointment for diabetic foot
WO2012044538A1 (en) 2010-09-27 2012-04-05 Advanced Technologies And Regenerative Medicine, Llc Medical devices with galvanic particulates
WO2012027728A3 (en) * 2010-08-27 2012-06-14 Sienna Labs, Inc. Compositions and methods for targeted thermomodulation
WO2012173312A1 (en) * 2011-06-17 2012-12-20 부산대학교 산학협력단 Cosmetic composition for preventing skin aging, containing as an active ingredient gold nanoparticles surface-treated with phytochemicals
US8475689B2 (en) 2003-06-30 2013-07-02 Johnson & Johnson Consumer Companies, Inc. Topical composition containing galvanic particulates
US9028851B2 (en) 2011-12-21 2015-05-12 Ethicon, Inc. Hemostatic materials and devices with galvanic particulates
US9044397B2 (en) 2009-03-27 2015-06-02 Ethicon, Inc. Medical devices with galvanic particulates
WO2015184347A1 (en) * 2014-05-29 2015-12-03 Metabeauty, Inc. Methods and compositions for the use of silver to prevent and treat acne
US9212294B2 (en) 2012-10-11 2015-12-15 Nanocomposix, Inc. Silver nanoplate compositions and methods
US9333258B2 (en) 2012-05-08 2016-05-10 The Regents Of The University Of California Fine spatiotemporal control of fat removal using NIR light
US9522289B2 (en) 2012-05-08 2016-12-20 The Regents Of The University Of California Selective fat removal using photothermal heating
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9624973B2 (en) * 2012-03-19 2017-04-18 Samsung Electronics Co., Ltd. Apparatus having friction preventing function and method of manufacturing the same
US10035969B2 (en) * 2016-07-22 2018-07-31 United Technologies Corporation Auxiliary emergency protective lubrication system for metal mechanical components
US10087320B2 (en) 2017-02-17 2018-10-02 Polydrop, Llc Conductive polymer-matrix compositions and uses thereof
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11491265B2 (en) 2017-02-22 2022-11-08 Cornell University Mechanical vacuum dressing for mechanically managing, protecting and suctioning small incisional wounds
US11839527B2 (en) 2017-12-06 2023-12-12 Cornell University Manually-operated negative pressure wound therapy (NPWT) bandage with improved pump efficiency, automatic pressure indicator and automatic pressure limiter

Families Citing this family (513)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070084897A1 (en) 2003-05-20 2007-04-19 Shelton Frederick E Iv Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism
US9060770B2 (en) 2003-05-20 2015-06-23 Ethicon Endo-Surgery, Inc. Robotically-driven surgical instrument with E-beam driver
US11890012B2 (en) 2004-07-28 2024-02-06 Cilag Gmbh International Staple cartridge comprising cartridge body and attached support
US8215531B2 (en) 2004-07-28 2012-07-10 Ethicon Endo-Surgery, Inc. Surgical stapling instrument having a medical substance dispenser
US20060029567A1 (en) * 2004-08-04 2006-02-09 Bki Holding Corporation Material for odor control
JP5082189B2 (en) * 2005-01-14 2012-11-28 大日本印刷株式会社 Coating liquid, metal oxide film and method for forming the same
WO2006126823A1 (en) * 2005-05-25 2006-11-30 Posco Ag-containing solution, antibacterial resin composition comprising the solution and antibacterial resin coated steel plate
FR2889649A1 (en) * 2005-08-11 2007-02-16 Eastman Kodak Co Use of a dispersion of silver in imogolite and/or allophane matrix as antiseptic agent for the manufacture of bandages
US7934630B2 (en) 2005-08-31 2011-05-03 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US9237891B2 (en) 2005-08-31 2016-01-19 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical stapling devices that produce formed staples having different lengths
US11246590B2 (en) 2005-08-31 2022-02-15 Cilag Gmbh International Staple cartridge including staple drivers having different unfired heights
US11484312B2 (en) 2005-08-31 2022-11-01 Cilag Gmbh International Staple cartridge comprising a staple driver arrangement
US10159482B2 (en) 2005-08-31 2018-12-25 Ethicon Llc Fastener cartridge assembly comprising a fixed anvil and different staple heights
US7669746B2 (en) 2005-08-31 2010-03-02 Ethicon Endo-Surgery, Inc. Staple cartridges for forming staples having differing formed staple heights
US20070194082A1 (en) 2005-08-31 2007-08-23 Morgan Jerome R Surgical stapling device with anvil having staple forming pockets of varying depths
EP1762352A1 (en) * 2005-09-12 2007-03-14 Nederlandse Organisatie voor Toegepast-Natuuurwetenschappelijk Onderzoek TNO Method for incorporating a functional additive within a porous material
US20070106317A1 (en) 2005-11-09 2007-05-10 Shelton Frederick E Iv Hydraulically and electrically actuated articulation joints for surgical instruments
US11793518B2 (en) 2006-01-31 2023-10-24 Cilag Gmbh International Powered surgical instruments with firing system lockout arrangements
US8708213B2 (en) 2006-01-31 2014-04-29 Ethicon Endo-Surgery, Inc. Surgical instrument having a feedback system
US11224427B2 (en) 2006-01-31 2022-01-18 Cilag Gmbh International Surgical stapling system including a console and retraction assembly
US8820603B2 (en) 2006-01-31 2014-09-02 Ethicon Endo-Surgery, Inc. Accessing data stored in a memory of a surgical instrument
US8186555B2 (en) 2006-01-31 2012-05-29 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting and fastening instrument with mechanical closure system
US20110006101A1 (en) 2009-02-06 2011-01-13 EthiconEndo-Surgery, Inc. Motor driven surgical fastener device with cutting member lockout arrangements
US7753904B2 (en) 2006-01-31 2010-07-13 Ethicon Endo-Surgery, Inc. Endoscopic surgical instrument with a handle that can articulate with respect to the shaft
US20120292367A1 (en) 2006-01-31 2012-11-22 Ethicon Endo-Surgery, Inc. Robotically-controlled end effector
US7845537B2 (en) 2006-01-31 2010-12-07 Ethicon Endo-Surgery, Inc. Surgical instrument having recording capabilities
US11278279B2 (en) 2006-01-31 2022-03-22 Cilag Gmbh International Surgical instrument assembly
US9861359B2 (en) 2006-01-31 2018-01-09 Ethicon Llc Powered surgical instruments with firing system lockout arrangements
US20110024477A1 (en) 2009-02-06 2011-02-03 Hall Steven G Driven Surgical Stapler Improvements
US20110290856A1 (en) 2006-01-31 2011-12-01 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical instrument with force-feedback capabilities
JP2007223917A (en) * 2006-02-21 2007-09-06 Nippon Chem Ind Co Ltd Antimicrobial agent
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
US20070225562A1 (en) 2006-03-23 2007-09-27 Ethicon Endo-Surgery, Inc. Articulating endoscopic accessory channel
EP1852497A1 (en) * 2006-05-03 2007-11-07 Carl Freudenberg KG Antimicrobial layer and use thereof
WO2007124800A1 (en) * 2006-05-03 2007-11-08 Carl Freudenberg Kg Antimicrobial layer and the use of this layer
WO2008020460A1 (en) 2006-06-14 2008-02-21 Nm Tech Ltd. Nanomaterials And Microdevices Technology Nanomaterial coatings for osteointegrated biomedical prostheses
US8322455B2 (en) 2006-06-27 2012-12-04 Ethicon Endo-Surgery, Inc. Manually driven surgical cutting and fastening instrument
WO2008006220A1 (en) * 2006-07-14 2008-01-17 The Governors Of The University Of Alberta Chabazite type zeolite supported metallic nanodots
US20080011163A1 (en) * 2006-07-17 2008-01-17 Mcclain Michael S Sorbent porous polymeric composite materials
US8202614B2 (en) * 2006-08-09 2012-06-19 Luna Innovations Incorporated Additive particles having superhydrophobic characteristics and coatings and methods of making and using the same
WO2008045022A2 (en) * 2006-08-09 2008-04-17 Luna Innovations Incorporated Additive particles having superhydrophobic characteristics and coatings and methods of making and using the same
US10568652B2 (en) 2006-09-29 2020-02-25 Ethicon Llc Surgical staples having attached drivers of different heights and stapling instruments for deploying the same
US10130359B2 (en) 2006-09-29 2018-11-20 Ethicon Llc Method for forming a staple
US7506791B2 (en) 2006-09-29 2009-03-24 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with mechanical mechanism for limiting maximum tissue compression
JP2010505887A (en) * 2006-10-12 2010-02-25 エヌエム テック ナノマテリアルズ マイクロディバイス テクノロジー リミテッド Materials, items and products comprising compositions having antimicrobial properties
US8092814B2 (en) 2006-10-30 2012-01-10 Mcneil-Ppc, Inc. Cover material for an absorbent article including a skin care composition and an absorbent article having a cover material including a skin care composition
US8778817B2 (en) 2006-10-30 2014-07-15 Mcneil-Ppc, Inc. Method of making a cover material including a skin care composition
AU2013206359A1 (en) * 2006-10-30 2013-07-04 Mcneil-Ppc, Inc. Cover material for an absorbent article including a skin care composition and an absorbent article having a cover material including a skin care composition
CA2669837C (en) * 2006-11-16 2016-07-05 Multisorb Technologies, Inc. Clean, compressed sorbent tablets
US11291441B2 (en) 2007-01-10 2022-04-05 Cilag Gmbh International Surgical instrument with wireless communication between control unit and remote sensor
US8684253B2 (en) 2007-01-10 2014-04-01 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor
US8652120B2 (en) 2007-01-10 2014-02-18 Ethicon Endo-Surgery, Inc. Surgical instrument with wireless communication between control unit and sensor transponders
US11039836B2 (en) 2007-01-11 2021-06-22 Cilag Gmbh International Staple cartridge for use with a surgical stapling instrument
US7434717B2 (en) 2007-01-11 2008-10-14 Ethicon Endo-Surgery, Inc. Apparatus for closing a curved anvil of a surgical stapling device
US20090001130A1 (en) 2007-03-15 2009-01-01 Hess Christopher J Surgical procedure using a cutting and stapling instrument having releasable staple-forming pockets
US8893946B2 (en) 2007-03-28 2014-11-25 Ethicon Endo-Surgery, Inc. Laparoscopic tissue thickness and clamp load measuring devices
US20100150980A1 (en) * 2007-04-04 2010-06-17 Perlen Converting Ag Antimicrobial material
US11672531B2 (en) 2007-06-04 2023-06-13 Cilag Gmbh International Rotary drive systems for surgical instruments
US8931682B2 (en) 2007-06-04 2015-01-13 Ethicon Endo-Surgery, Inc. Robotically-controlled shaft based rotary drive systems for surgical instruments
US8408439B2 (en) 2007-06-22 2013-04-02 Ethicon Endo-Surgery, Inc. Surgical stapling instrument with an articulatable end effector
US7753245B2 (en) 2007-06-22 2010-07-13 Ethicon Endo-Surgery, Inc. Surgical stapling instruments
US11849941B2 (en) 2007-06-29 2023-12-26 Cilag Gmbh International Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis
JP4561837B2 (en) * 2008-01-07 2010-10-13 日本電気株式会社 REPRODUCTION DEVICE, SYSTEM, METHOD, PROGRAM, AND COMPUTER-READABLE RECORDING MEDIUM
GB2457294A (en) * 2008-02-08 2009-08-12 Sun Chemical Ltd Oxygen barrier coating composition
US8561870B2 (en) 2008-02-13 2013-10-22 Ethicon Endo-Surgery, Inc. Surgical stapling instrument
US7866527B2 (en) 2008-02-14 2011-01-11 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with interlockable firing system
US8573465B2 (en) 2008-02-14 2013-11-05 Ethicon Endo-Surgery, Inc. Robotically-controlled surgical end effector system with rotary actuated closure systems
US7819298B2 (en) 2008-02-14 2010-10-26 Ethicon Endo-Surgery, Inc. Surgical stapling apparatus with control features operable with one hand
US8657174B2 (en) 2008-02-14 2014-02-25 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument having handle based power source
US8636736B2 (en) 2008-02-14 2014-01-28 Ethicon Endo-Surgery, Inc. Motorized surgical cutting and fastening instrument
US9179912B2 (en) 2008-02-14 2015-11-10 Ethicon Endo-Surgery, Inc. Robotically-controlled motorized surgical cutting and fastening instrument
US8758391B2 (en) 2008-02-14 2014-06-24 Ethicon Endo-Surgery, Inc. Interchangeable tools for surgical instruments
RU2493788C2 (en) 2008-02-14 2013-09-27 Этикон Эндо-Серджери, Инк. Surgical cutting and fixing instrument, which has radio-frequency electrodes
US11272927B2 (en) 2008-02-15 2022-03-15 Cilag Gmbh International Layer arrangements for surgical staple cartridges
US20090206131A1 (en) 2008-02-15 2009-08-20 Ethicon Endo-Surgery, Inc. End effector coupling arrangements for a surgical cutting and stapling instrument
US9585657B2 (en) 2008-02-15 2017-03-07 Ethicon Endo-Surgery, Llc Actuator for releasing a layer of material from a surgical end effector
US7954686B2 (en) 2008-09-19 2011-06-07 Ethicon Endo-Surgery, Inc. Surgical stapler with apparatus for adjusting staple height
US9386983B2 (en) 2008-09-23 2016-07-12 Ethicon Endo-Surgery, Llc Robotically-controlled motorized surgical instrument
US8210411B2 (en) 2008-09-23 2012-07-03 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting instrument
US9005230B2 (en) 2008-09-23 2015-04-14 Ethicon Endo-Surgery, Inc. Motorized surgical instrument
US11648005B2 (en) 2008-09-23 2023-05-16 Cilag Gmbh International Robotically-controlled motorized surgical instrument with an end effector
US8608045B2 (en) 2008-10-10 2013-12-17 Ethicon Endo-Sugery, Inc. Powered surgical cutting and stapling apparatus with manually retractable firing system
US8517239B2 (en) 2009-02-05 2013-08-27 Ethicon Endo-Surgery, Inc. Surgical stapling instrument comprising a magnetic element driver
RU2525225C2 (en) 2009-02-06 2014-08-10 Этикон Эндо-Серджери, Инк. Improvement of drive surgical suturing instrument
US8444036B2 (en) 2009-02-06 2013-05-21 Ethicon Endo-Surgery, Inc. Motor driven surgical fastener device with mechanisms for adjusting a tissue gap within the end effector
TW201102363A (en) * 2009-07-01 2011-01-16 Univ Nat Taiwan Polymeric polymer including poly(oxyethylene)-amine and method for producing silver nanoparticle by employing the same
FR2952306B1 (en) * 2009-11-09 2012-03-30 Creaspine AQUEOUS COMPOSITION FOR THE TREATMENT OF LASER FIBROUS CONJUNCTIVE TISSUE REPAIR
US8851354B2 (en) 2009-12-24 2014-10-07 Ethicon Endo-Surgery, Inc. Surgical cutting instrument that analyzes tissue thickness
US8220688B2 (en) 2009-12-24 2012-07-17 Ethicon Endo-Surgery, Inc. Motor-driven surgical cutting instrument with electric actuator directional control assembly
US8608046B2 (en) 2010-01-07 2013-12-17 Ethicon Endo-Surgery, Inc. Test device for a surgical tool
RU2419455C1 (en) * 2010-03-03 2011-05-27 Закрытое акционерное общество "Институт прикладной нанотехнологии" Hygienic product with antimicrobial and antifungal properties
US8822386B2 (en) 2010-06-28 2014-09-02 Baker Hughes Incorporated Nanofluids and methods of use for drilling and completion fluids
US8783543B2 (en) 2010-07-30 2014-07-22 Ethicon Endo-Surgery, Inc. Tissue acquisition arrangements and methods for surgical stapling devices
US8360296B2 (en) 2010-09-09 2013-01-29 Ethicon Endo-Surgery, Inc. Surgical stapling head assembly with firing lockout for a surgical stapler
US9289212B2 (en) 2010-09-17 2016-03-22 Ethicon Endo-Surgery, Inc. Surgical instruments and batteries for surgical instruments
US8632525B2 (en) 2010-09-17 2014-01-21 Ethicon Endo-Surgery, Inc. Power control arrangements for surgical instruments and batteries
US8733613B2 (en) 2010-09-29 2014-05-27 Ethicon Endo-Surgery, Inc. Staple cartridge
US11849952B2 (en) 2010-09-30 2023-12-26 Cilag Gmbh International Staple cartridge comprising staples positioned within a compressible portion thereof
US11812965B2 (en) 2010-09-30 2023-11-14 Cilag Gmbh International Layer of material for a surgical end effector
US9277919B2 (en) 2010-09-30 2016-03-08 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprising fibers to produce a resilient load
US9629814B2 (en) 2010-09-30 2017-04-25 Ethicon Endo-Surgery, Llc Tissue thickness compensator configured to redistribute compressive forces
US10945731B2 (en) 2010-09-30 2021-03-16 Ethicon Llc Tissue thickness compensator comprising controlled release and expansion
US9364233B2 (en) 2010-09-30 2016-06-14 Ethicon Endo-Surgery, Llc Tissue thickness compensators for circular surgical staplers
US9332974B2 (en) 2010-09-30 2016-05-10 Ethicon Endo-Surgery, Llc Layered tissue thickness compensator
US9220501B2 (en) 2010-09-30 2015-12-29 Ethicon Endo-Surgery, Inc. Tissue thickness compensators
US9414838B2 (en) 2012-03-28 2016-08-16 Ethicon Endo-Surgery, Llc Tissue thickness compensator comprised of a plurality of materials
US9386988B2 (en) 2010-09-30 2016-07-12 Ethicon End-Surgery, LLC Retainer assembly including a tissue thickness compensator
RU2013119928A (en) 2010-09-30 2014-11-10 Этикон Эндо-Серджери, Инк. A STAPLING SYSTEM CONTAINING A RETAINING MATRIX AND A LEVELING MATRIX
US9301753B2 (en) 2010-09-30 2016-04-05 Ethicon Endo-Surgery, Llc Expandable tissue thickness compensator
US9307989B2 (en) 2012-03-28 2016-04-12 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorportating a hydrophobic agent
US20120080498A1 (en) 2010-09-30 2012-04-05 Ethicon Endo-Surgery, Inc. Curved end effector for a stapling instrument
US8857694B2 (en) 2010-09-30 2014-10-14 Ethicon Endo-Surgery, Inc. Staple cartridge loading assembly
US9839420B2 (en) 2010-09-30 2017-12-12 Ethicon Llc Tissue thickness compensator comprising at least one medicament
US9700317B2 (en) 2010-09-30 2017-07-11 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a releasable tissue thickness compensator
US9517063B2 (en) * 2012-03-28 2016-12-13 Ethicon Endo-Surgery, Llc Movable member for use with a tissue thickness compensator
US9314246B2 (en) 2010-09-30 2016-04-19 Ethicon Endo-Surgery, Llc Tissue stapler having a thickness compensator incorporating an anti-inflammatory agent
US11298125B2 (en) 2010-09-30 2022-04-12 Cilag Gmbh International Tissue stapler having a thickness compensator
US8695866B2 (en) 2010-10-01 2014-04-15 Ethicon Endo-Surgery, Inc. Surgical instrument having a power control circuit
EP2461655A1 (en) * 2010-12-06 2012-06-06 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Hybrid materials for printing conductive or semiconductive elements
US20120231251A1 (en) * 2011-03-09 2012-09-13 Samsung Electronics Co., Ltd. Composition for clay-aerogel composite, clay-aerogel composite, and method of making the same
US9211122B2 (en) 2011-03-14 2015-12-15 Ethicon Endo-Surgery, Inc. Surgical access devices with anvil introduction and specimen retrieval structures
AU2012250197B2 (en) 2011-04-29 2017-08-10 Ethicon Endo-Surgery, Inc. Staple cartridge comprising staples positioned within a compressible portion thereof
US11207064B2 (en) 2011-05-27 2021-12-28 Cilag Gmbh International Automated end effector component reloading system for use with a robotic system
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
EP2747793A1 (en) * 2011-08-23 2014-07-02 Birgit Riesinger Absorbent hygienic or personal care product having a strip-like component with a content of at least one heavy metal present in elemental or ionic form
US9050084B2 (en) 2011-09-23 2015-06-09 Ethicon Endo-Surgery, Inc. Staple cartridge including collapsible deck arrangement
WO2013044202A1 (en) * 2011-09-25 2013-03-28 Waukesha Electric Systems, Inc. Insulation for power transformers
US9044230B2 (en) 2012-02-13 2015-06-02 Ethicon Endo-Surgery, Inc. Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status
JP5924807B2 (en) * 2012-02-14 2016-05-25 日本フイルコン株式会社 Gel-like metal adsorbent and gel-like metal adsorbent-carrying adsorbent
US9386816B2 (en) 2012-02-14 2016-07-12 International Textile Group, Inc. Fire resistant garments containing a high lubricity thermal liner
US8784773B2 (en) * 2012-02-25 2014-07-22 Mohammad Mojmeli Renani Hydrogel nanocomposite wound dressing and a method of synthesizing the same
US9078653B2 (en) 2012-03-26 2015-07-14 Ethicon Endo-Surgery, Inc. Surgical stapling device with lockout system for preventing actuation in the absence of an installed staple cartridge
MX358135B (en) 2012-03-28 2018-08-06 Ethicon Endo Surgery Inc Tissue thickness compensator comprising a plurality of layers.
US9198662B2 (en) 2012-03-28 2015-12-01 Ethicon Endo-Surgery, Inc. Tissue thickness compensator having improved visibility
MX350846B (en) 2012-03-28 2017-09-22 Ethicon Endo Surgery Inc Tissue thickness compensator comprising capsules defining a low pressure environment.
CN104379068B (en) 2012-03-28 2017-09-22 伊西康内外科公司 Holding device assembly including tissue thickness compensation part
US10037831B2 (en) 2012-04-12 2018-07-31 Sol Voltaics Ab Methods of nanowire functionalization, dispersion and attachment
US9101358B2 (en) 2012-06-15 2015-08-11 Ethicon Endo-Surgery, Inc. Articulatable surgical instrument comprising a firing drive
US9028494B2 (en) 2012-06-28 2015-05-12 Ethicon Endo-Surgery, Inc. Interchangeable end effector coupling arrangement
US20140001231A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Firing system lockout arrangements for surgical instruments
US9101385B2 (en) 2012-06-28 2015-08-11 Ethicon Endo-Surgery, Inc. Electrode connections for rotary driven surgical tools
US9125662B2 (en) 2012-06-28 2015-09-08 Ethicon Endo-Surgery, Inc. Multi-axis articulating and rotating surgical tools
US9072536B2 (en) 2012-06-28 2015-07-07 Ethicon Endo-Surgery, Inc. Differential locking arrangements for rotary powered surgical instruments
JP6290201B2 (en) 2012-06-28 2018-03-07 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Lockout for empty clip cartridge
US11202631B2 (en) 2012-06-28 2021-12-21 Cilag Gmbh International Stapling assembly comprising a firing lockout
US9289256B2 (en) 2012-06-28 2016-03-22 Ethicon Endo-Surgery, Llc Surgical end effectors having angled tissue-contacting surfaces
US9119657B2 (en) 2012-06-28 2015-09-01 Ethicon Endo-Surgery, Inc. Rotary actuatable closure arrangement for surgical end effector
US9649111B2 (en) 2012-06-28 2017-05-16 Ethicon Endo-Surgery, Llc Replaceable clip cartridge for a clip applier
US9561038B2 (en) 2012-06-28 2017-02-07 Ethicon Endo-Surgery, Llc Interchangeable clip applier
US20140005718A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Multi-functional powered surgical device with external dissection features
US20140005678A1 (en) 2012-06-28 2014-01-02 Ethicon Endo-Surgery, Inc. Rotary drive arrangements for surgical instruments
BR112014032776B1 (en) 2012-06-28 2021-09-08 Ethicon Endo-Surgery, Inc SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM
US9386985B2 (en) 2012-10-15 2016-07-12 Ethicon Endo-Surgery, Llc Surgical cutting instrument
US9394637B2 (en) 2012-12-13 2016-07-19 Jacob Holm & Sons Ag Method for production of a hydroentangled airlaid web and products obtained therefrom
US9386984B2 (en) 2013-02-08 2016-07-12 Ethicon Endo-Surgery, Llc Staple cartridge comprising a releasable cover
MX364729B (en) 2013-03-01 2019-05-06 Ethicon Endo Surgery Inc Surgical instrument with a soft stop.
US9307986B2 (en) 2013-03-01 2016-04-12 Ethicon Endo-Surgery, Llc Surgical instrument soft stop
JP6382235B2 (en) 2013-03-01 2018-08-29 エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. Articulatable surgical instrument with a conductive path for signal communication
US9345481B2 (en) 2013-03-13 2016-05-24 Ethicon Endo-Surgery, Llc Staple cartridge tissue thickness sensor system
US9808244B2 (en) 2013-03-14 2017-11-07 Ethicon Llc Sensor arrangements for absolute positioning system for surgical instruments
US9629629B2 (en) 2013-03-14 2017-04-25 Ethicon Endo-Surgey, LLC Control systems for surgical instruments
US9795384B2 (en) 2013-03-27 2017-10-24 Ethicon Llc Fastener cartridge comprising a tissue thickness compensator and a gap setting element
US9572577B2 (en) 2013-03-27 2017-02-21 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a tissue thickness compensator including openings therein
US9332984B2 (en) 2013-03-27 2016-05-10 Ethicon Endo-Surgery, Llc Fastener cartridge assemblies
US9826976B2 (en) 2013-04-16 2017-11-28 Ethicon Llc Motor driven surgical instruments with lockable dual drive shafts
BR112015026109B1 (en) 2013-04-16 2022-02-22 Ethicon Endo-Surgery, Inc surgical instrument
EP2986754B1 (en) * 2013-04-18 2017-03-22 3M Innovative Properties Company Nanosilica/clay compositions and coated articles, and methods of making the same
US9574644B2 (en) 2013-05-30 2017-02-21 Ethicon Endo-Surgery, Llc Power module for use with a surgical instrument
US9808249B2 (en) 2013-08-23 2017-11-07 Ethicon Llc Attachment portions for surgical instrument assemblies
MX369362B (en) 2013-08-23 2019-11-06 Ethicon Endo Surgery Llc Firing member retraction devices for powered surgical instruments.
US9180346B2 (en) 2013-10-23 2015-11-10 Acushnet Company Golf balls having foam center containing clay particulate
DE102013114586A1 (en) * 2013-12-20 2015-06-25 Teng-Lai Chen Sterilization and deodorization structure of a personal care article
US9724092B2 (en) 2013-12-23 2017-08-08 Ethicon Llc Modular surgical instruments
US9642620B2 (en) 2013-12-23 2017-05-09 Ethicon Endo-Surgery, Llc Surgical cutting and stapling instruments with articulatable end effectors
US9839428B2 (en) 2013-12-23 2017-12-12 Ethicon Llc Surgical cutting and stapling instruments with independent jaw control features
US9681870B2 (en) 2013-12-23 2017-06-20 Ethicon Llc Articulatable surgical instruments with separate and distinct closing and firing systems
US9549735B2 (en) 2013-12-23 2017-01-24 Ethicon Endo-Surgery, Llc Fastener cartridge comprising a firing member including fastener transfer surfaces
US20150173756A1 (en) 2013-12-23 2015-06-25 Ethicon Endo-Surgery, Inc. Surgical cutting and stapling methods
US9962161B2 (en) 2014-02-12 2018-05-08 Ethicon Llc Deliverable surgical instrument
US20140166726A1 (en) 2014-02-24 2014-06-19 Ethicon Endo-Surgery, Inc. Staple cartridge including a barbed staple
CN106232029B (en) 2014-02-24 2019-04-12 伊西康内外科有限责任公司 Fastening system including firing member locking piece
US20150272557A1 (en) 2014-03-26 2015-10-01 Ethicon Endo-Surgery, Inc. Modular surgical instrument system
US9826977B2 (en) 2014-03-26 2017-11-28 Ethicon Llc Sterilization verification circuit
US9913642B2 (en) 2014-03-26 2018-03-13 Ethicon Llc Surgical instrument comprising a sensor system
US10201364B2 (en) 2014-03-26 2019-02-12 Ethicon Llc Surgical instrument comprising a rotatable shaft
BR112016021943B1 (en) 2014-03-26 2022-06-14 Ethicon Endo-Surgery, Llc SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE
TR201900969T4 (en) * 2014-04-09 2019-02-21 Invista Textiles U K Ltd Waterproof, dirt-resistant, fluorine-free compositions.
US20150297223A1 (en) 2014-04-16 2015-10-22 Ethicon Endo-Surgery, Inc. Fastener cartridges including extensions having different configurations
US9801628B2 (en) 2014-09-26 2017-10-31 Ethicon Llc Surgical staple and driver arrangements for staple cartridges
JP6612256B2 (en) 2014-04-16 2019-11-27 エシコン エルエルシー Fastener cartridge with non-uniform fastener
US10542988B2 (en) 2014-04-16 2020-01-28 Ethicon Llc End effector comprising an anvil including projections extending therefrom
BR112016023807B1 (en) 2014-04-16 2022-07-12 Ethicon Endo-Surgery, Llc CARTRIDGE SET OF FASTENERS FOR USE WITH A SURGICAL INSTRUMENT
CN106456176B (en) 2014-04-16 2019-06-28 伊西康内外科有限责任公司 Fastener cartridge including the extension with various configuration
US10045781B2 (en) 2014-06-13 2018-08-14 Ethicon Llc Closure lockout systems for surgical instruments
JP5901703B2 (en) * 2014-06-30 2016-04-13 ユニ・チャーム株式会社 Liquid material coating method and liquid material coating apparatus
US11311294B2 (en) 2014-09-05 2022-04-26 Cilag Gmbh International Powered medical device including measurement of closure state of jaws
US9724094B2 (en) 2014-09-05 2017-08-08 Ethicon Llc Adjunct with integrated sensors to quantify tissue compression
BR112017004361B1 (en) 2014-09-05 2023-04-11 Ethicon Llc ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT
US10105142B2 (en) 2014-09-18 2018-10-23 Ethicon Llc Surgical stapler with plurality of cutting elements
CN107427300B (en) 2014-09-26 2020-12-04 伊西康有限责任公司 Surgical suture buttress and buttress material
US11523821B2 (en) 2014-09-26 2022-12-13 Cilag Gmbh International Method for creating a flexible staple line
US10076325B2 (en) 2014-10-13 2018-09-18 Ethicon Llc Surgical stapling apparatus comprising a tissue stop
US9924944B2 (en) 2014-10-16 2018-03-27 Ethicon Llc Staple cartridge comprising an adjunct material
US11141153B2 (en) 2014-10-29 2021-10-12 Cilag Gmbh International Staple cartridges comprising driver arrangements
US10517594B2 (en) 2014-10-29 2019-12-31 Ethicon Llc Cartridge assemblies for surgical staplers
US9844376B2 (en) 2014-11-06 2017-12-19 Ethicon Llc Staple cartridge comprising a releasable adjunct material
US10736636B2 (en) 2014-12-10 2020-08-11 Ethicon Llc Articulatable surgical instrument system
US9844374B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member
US9987000B2 (en) 2014-12-18 2018-06-05 Ethicon Llc Surgical instrument assembly comprising a flexible articulation system
US10117649B2 (en) 2014-12-18 2018-11-06 Ethicon Llc Surgical instrument assembly comprising a lockable articulation system
US9844375B2 (en) 2014-12-18 2017-12-19 Ethicon Llc Drive arrangements for articulatable surgical instruments
BR112017012996B1 (en) 2014-12-18 2022-11-08 Ethicon Llc SURGICAL INSTRUMENT WITH AN ANvil WHICH IS SELECTIVELY MOVABLE ABOUT AN IMMOVABLE GEOMETRIC AXIS DIFFERENT FROM A STAPLE CARTRIDGE
US10188385B2 (en) 2014-12-18 2019-01-29 Ethicon Llc Surgical instrument system comprising lockable systems
US10245027B2 (en) 2014-12-18 2019-04-02 Ethicon Llc Surgical instrument with an anvil that is selectively movable about a discrete non-movable axis relative to a staple cartridge
US10085748B2 (en) 2014-12-18 2018-10-02 Ethicon Llc Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors
US11154301B2 (en) 2015-02-27 2021-10-26 Cilag Gmbh International Modular stapling assembly
US10180463B2 (en) 2015-02-27 2019-01-15 Ethicon Llc Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band
US10245028B2 (en) 2015-02-27 2019-04-02 Ethicon Llc Power adapter for a surgical instrument
US9993258B2 (en) 2015-02-27 2018-06-12 Ethicon Llc Adaptable surgical instrument handle
JP2020121162A (en) 2015-03-06 2020-08-13 エシコン エルエルシーEthicon LLC Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement
US9901342B2 (en) 2015-03-06 2018-02-27 Ethicon Endo-Surgery, Llc Signal and power communication system positioned on a rotatable shaft
US9808246B2 (en) 2015-03-06 2017-11-07 Ethicon Endo-Surgery, Llc Method of operating a powered surgical instrument
US10045776B2 (en) 2015-03-06 2018-08-14 Ethicon Llc Control techniques and sub-processor contained within modular shaft with select control processing from handle
US9895148B2 (en) 2015-03-06 2018-02-20 Ethicon Endo-Surgery, Llc Monitoring speed control and precision incrementing of motor for powered surgical instruments
US9993248B2 (en) 2015-03-06 2018-06-12 Ethicon Endo-Surgery, Llc Smart sensors with local signal processing
US10687806B2 (en) 2015-03-06 2020-06-23 Ethicon Llc Adaptive tissue compression techniques to adjust closure rates for multiple tissue types
US10052044B2 (en) 2015-03-06 2018-08-21 Ethicon Llc Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures
US10245033B2 (en) 2015-03-06 2019-04-02 Ethicon Llc Surgical instrument comprising a lockable battery housing
US10441279B2 (en) 2015-03-06 2019-10-15 Ethicon Llc Multiple level thresholds to modify operation of powered surgical instruments
US9924961B2 (en) 2015-03-06 2018-03-27 Ethicon Endo-Surgery, Llc Interactive feedback system for powered surgical instruments
US10617412B2 (en) 2015-03-06 2020-04-14 Ethicon Llc System for detecting the mis-insertion of a staple cartridge into a surgical stapler
US10213201B2 (en) 2015-03-31 2019-02-26 Ethicon Llc Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw
US10405594B2 (en) 2015-05-21 2019-09-10 International Textile Group, Inc. Inner lining fabric
US10405863B2 (en) 2015-06-18 2019-09-10 Ethicon Llc Movable firing beam support arrangements for articulatable surgical instruments
US11058425B2 (en) 2015-08-17 2021-07-13 Ethicon Llc Implantable layers for a surgical instrument
US10028744B2 (en) 2015-08-26 2018-07-24 Ethicon Llc Staple cartridge assembly including staple guides
MX2018002388A (en) 2015-08-26 2018-08-01 Ethicon Llc Surgical staple strips for permitting varying staple properties and enabling easy cartridge loading.
US10172619B2 (en) 2015-09-02 2019-01-08 Ethicon Llc Surgical staple driver arrays
MX2022006191A (en) 2015-09-02 2022-06-16 Ethicon Llc Surgical staple configurations with camming surfaces located between portions supporting surgical staples.
US10105139B2 (en) 2015-09-23 2018-10-23 Ethicon Llc Surgical stapler having downstream current-based motor control
US10363036B2 (en) 2015-09-23 2019-07-30 Ethicon Llc Surgical stapler having force-based motor control
US10076326B2 (en) 2015-09-23 2018-09-18 Ethicon Llc Surgical stapler having current mirror-based motor control
US10238386B2 (en) 2015-09-23 2019-03-26 Ethicon Llc Surgical stapler having motor control based on an electrical parameter related to a motor current
US10085751B2 (en) 2015-09-23 2018-10-02 Ethicon Llc Surgical stapler having temperature-based motor control
US10327769B2 (en) 2015-09-23 2019-06-25 Ethicon Llc Surgical stapler having motor control based on a drive system component
US10299878B2 (en) 2015-09-25 2019-05-28 Ethicon Llc Implantable adjunct systems for determining adjunct skew
US10285699B2 (en) 2015-09-30 2019-05-14 Ethicon Llc Compressible adjunct
US11890015B2 (en) 2015-09-30 2024-02-06 Cilag Gmbh International Compressible adjunct with crossing spacer fibers
US10524788B2 (en) 2015-09-30 2020-01-07 Ethicon Llc Compressible adjunct with attachment regions
US10980539B2 (en) 2015-09-30 2021-04-20 Ethicon Llc Implantable adjunct comprising bonded layers
US10327480B2 (en) * 2015-12-21 2019-06-25 Misbah Khan Disposable liners for body areas
US10368865B2 (en) 2015-12-30 2019-08-06 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10265068B2 (en) 2015-12-30 2019-04-23 Ethicon Llc Surgical instruments with separable motors and motor control circuits
US10292704B2 (en) 2015-12-30 2019-05-21 Ethicon Llc Mechanisms for compensating for battery pack failure in powered surgical instruments
US11213293B2 (en) 2016-02-09 2022-01-04 Cilag Gmbh International Articulatable surgical instruments with single articulation link arrangements
US10588625B2 (en) 2016-02-09 2020-03-17 Ethicon Llc Articulatable surgical instruments with off-axis firing beam arrangements
BR112018016098B1 (en) 2016-02-09 2023-02-23 Ethicon Llc SURGICAL INSTRUMENT
US10448948B2 (en) 2016-02-12 2019-10-22 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US11224426B2 (en) 2016-02-12 2022-01-18 Cilag Gmbh International Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10258331B2 (en) 2016-02-12 2019-04-16 Ethicon Llc Mechanisms for compensating for drivetrain failure in powered surgical instruments
US10709446B2 (en) 2016-04-01 2020-07-14 Ethicon Llc Staple cartridges with atraumatic features
US10617413B2 (en) 2016-04-01 2020-04-14 Ethicon Llc Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts
US10413293B2 (en) 2016-04-01 2019-09-17 Ethicon Llc Interchangeable surgical tool assembly with a surgical end effector that is selectively rotatable about a shaft axis
US11284890B2 (en) 2016-04-01 2022-03-29 Cilag Gmbh International Circular stapling system comprising an incisable tissue support
US11064997B2 (en) 2016-04-01 2021-07-20 Cilag Gmbh International Surgical stapling instrument
US10828028B2 (en) 2016-04-15 2020-11-10 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US10405859B2 (en) 2016-04-15 2019-09-10 Ethicon Llc Surgical instrument with adjustable stop/start control during a firing motion
US10335145B2 (en) 2016-04-15 2019-07-02 Ethicon Llc Modular surgical instrument with configurable operating mode
US10492783B2 (en) 2016-04-15 2019-12-03 Ethicon, Llc Surgical instrument with improved stop/start control during a firing motion
US10426467B2 (en) 2016-04-15 2019-10-01 Ethicon Llc Surgical instrument with detection sensors
US10357247B2 (en) 2016-04-15 2019-07-23 Ethicon Llc Surgical instrument with multiple program responses during a firing motion
US11607239B2 (en) 2016-04-15 2023-03-21 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US10456137B2 (en) 2016-04-15 2019-10-29 Ethicon Llc Staple formation detection mechanisms
US11179150B2 (en) 2016-04-15 2021-11-23 Cilag Gmbh International Systems and methods for controlling a surgical stapling and cutting instrument
US11317917B2 (en) 2016-04-18 2022-05-03 Cilag Gmbh International Surgical stapling system comprising a lockable firing assembly
US20170296173A1 (en) 2016-04-18 2017-10-19 Ethicon Endo-Surgery, Llc Method for operating a surgical instrument
US10363037B2 (en) 2016-04-18 2019-07-30 Ethicon Llc Surgical instrument system comprising a magnetic lockout
USD847989S1 (en) 2016-06-24 2019-05-07 Ethicon Llc Surgical fastener cartridge
USD826405S1 (en) 2016-06-24 2018-08-21 Ethicon Llc Surgical fastener
USD850617S1 (en) 2016-06-24 2019-06-04 Ethicon Llc Surgical fastener cartridge
CN109310431B (en) 2016-06-24 2022-03-04 伊西康有限责任公司 Staple cartridge comprising wire staples and punch staples
US11000278B2 (en) 2016-06-24 2021-05-11 Ethicon Llc Staple cartridge comprising wire staples and stamped staples
US10426471B2 (en) 2016-12-21 2019-10-01 Ethicon Llc Surgical instrument with multiple failure response modes
US10667809B2 (en) 2016-12-21 2020-06-02 Ethicon Llc Staple cartridge and staple cartridge channel comprising windows defined therein
US11419606B2 (en) 2016-12-21 2022-08-23 Cilag Gmbh International Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems
US10959727B2 (en) 2016-12-21 2021-03-30 Ethicon Llc Articulatable surgical end effector with asymmetric shaft arrangement
US10945727B2 (en) 2016-12-21 2021-03-16 Ethicon Llc Staple cartridge with deformable driver retention features
US10675025B2 (en) 2016-12-21 2020-06-09 Ethicon Llc Shaft assembly comprising separately actuatable and retractable systems
US20180168598A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Staple forming pocket arrangements comprising zoned forming surface grooves
US20180168615A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument
BR112019011947A2 (en) 2016-12-21 2019-10-29 Ethicon Llc surgical stapling systems
CN110099619B (en) 2016-12-21 2022-07-15 爱惜康有限责任公司 Lockout device for surgical end effector and replaceable tool assembly
US10568626B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Surgical instruments with jaw opening features for increasing a jaw opening distance
US10973516B2 (en) 2016-12-21 2021-04-13 Ethicon Llc Surgical end effectors and adaptable firing members therefor
US10687810B2 (en) 2016-12-21 2020-06-23 Ethicon Llc Stepped staple cartridge with tissue retention and gap setting features
US10758229B2 (en) 2016-12-21 2020-09-01 Ethicon Llc Surgical instrument comprising improved jaw control
US20180168648A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Durability features for end effectors and firing assemblies of surgical stapling instruments
US10993715B2 (en) 2016-12-21 2021-05-04 Ethicon Llc Staple cartridge comprising staples with different clamping breadths
US11134942B2 (en) 2016-12-21 2021-10-05 Cilag Gmbh International Surgical stapling instruments and staple-forming anvils
US11684367B2 (en) 2016-12-21 2023-06-27 Cilag Gmbh International Stepped assembly having and end-of-life indicator
US10568625B2 (en) 2016-12-21 2020-02-25 Ethicon Llc Staple cartridges and arrangements of staples and staple cavities therein
US20180168625A1 (en) 2016-12-21 2018-06-21 Ethicon Endo-Surgery, Llc Surgical stapling instruments with smart staple cartridges
US11090048B2 (en) 2016-12-21 2021-08-17 Cilag Gmbh International Method for resetting a fuse of a surgical instrument shaft
JP7010956B2 (en) 2016-12-21 2022-01-26 エシコン エルエルシー How to staple tissue
US10667810B2 (en) 2016-12-21 2020-06-02 Ethicon Llc Closure members with cam surface arrangements for surgical instruments with separate and distinct closure and firing systems
US10485543B2 (en) 2016-12-21 2019-11-26 Ethicon Llc Anvil having a knife slot width
JP2018102613A (en) * 2016-12-27 2018-07-05 花王株式会社 Absorbent article
CN110997131B (en) * 2017-05-18 2022-09-13 新加坡科技研究局 Composite structures and methods of forming the same
US10307170B2 (en) 2017-06-20 2019-06-04 Ethicon Llc Method for closed loop control of motor velocity of a surgical stapling and cutting instrument
US10881396B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Surgical instrument with variable duration trigger arrangement
US11090046B2 (en) 2017-06-20 2021-08-17 Cilag Gmbh International Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument
US10624633B2 (en) 2017-06-20 2020-04-21 Ethicon Llc Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument
US10779820B2 (en) 2017-06-20 2020-09-22 Ethicon Llc Systems and methods for controlling motor speed according to user input for a surgical instrument
US10368864B2 (en) 2017-06-20 2019-08-06 Ethicon Llc Systems and methods for controlling displaying motor velocity for a surgical instrument
US11382638B2 (en) 2017-06-20 2022-07-12 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance
US11071554B2 (en) 2017-06-20 2021-07-27 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements
USD879808S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with graphical user interface
US11653914B2 (en) 2017-06-20 2023-05-23 Cilag Gmbh International Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector
US10327767B2 (en) 2017-06-20 2019-06-25 Ethicon Llc Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation
USD890784S1 (en) 2017-06-20 2020-07-21 Ethicon Llc Display panel with changeable graphical user interface
US10881399B2 (en) 2017-06-20 2021-01-05 Ethicon Llc Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument
US10888321B2 (en) 2017-06-20 2021-01-12 Ethicon Llc Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument
US10813639B2 (en) 2017-06-20 2020-10-27 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions
USD879809S1 (en) 2017-06-20 2020-03-31 Ethicon Llc Display panel with changeable graphical user interface
US10980537B2 (en) 2017-06-20 2021-04-20 Ethicon Llc Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations
US10646220B2 (en) 2017-06-20 2020-05-12 Ethicon Llc Systems and methods for controlling displacement member velocity for a surgical instrument
US10390841B2 (en) 2017-06-20 2019-08-27 Ethicon Llc Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation
US11517325B2 (en) 2017-06-20 2022-12-06 Cilag Gmbh International Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval
US11266405B2 (en) 2017-06-27 2022-03-08 Cilag Gmbh International Surgical anvil manufacturing methods
US11324503B2 (en) 2017-06-27 2022-05-10 Cilag Gmbh International Surgical firing member arrangements
US10772629B2 (en) 2017-06-27 2020-09-15 Ethicon Llc Surgical anvil arrangements
US10993716B2 (en) 2017-06-27 2021-05-04 Ethicon Llc Surgical anvil arrangements
US20180368844A1 (en) 2017-06-27 2018-12-27 Ethicon Llc Staple forming pocket arrangements
US10856869B2 (en) 2017-06-27 2020-12-08 Ethicon Llc Surgical anvil arrangements
US11259805B2 (en) 2017-06-28 2022-03-01 Cilag Gmbh International Surgical instrument comprising firing member supports
US10716614B2 (en) 2017-06-28 2020-07-21 Ethicon Llc Surgical shaft assemblies with slip ring assemblies with increased contact pressure
US10211586B2 (en) 2017-06-28 2019-02-19 Ethicon Llc Surgical shaft assemblies with watertight housings
US11246592B2 (en) 2017-06-28 2022-02-15 Cilag Gmbh International Surgical instrument comprising an articulation system lockable to a frame
USD854151S1 (en) 2017-06-28 2019-07-16 Ethicon Llc Surgical instrument shaft
US11478242B2 (en) 2017-06-28 2022-10-25 Cilag Gmbh International Jaw retainer arrangement for retaining a pivotable surgical instrument jaw in pivotable retaining engagement with a second surgical instrument jaw
US11564686B2 (en) 2017-06-28 2023-01-31 Cilag Gmbh International Surgical shaft assemblies with flexible interfaces
USD906355S1 (en) 2017-06-28 2020-12-29 Ethicon Llc Display screen or portion thereof with a graphical user interface for a surgical instrument
EP4070740A1 (en) 2017-06-28 2022-10-12 Cilag GmbH International Surgical instrument comprising selectively actuatable rotatable couplers
USD869655S1 (en) 2017-06-28 2019-12-10 Ethicon Llc Surgical fastener cartridge
US10765427B2 (en) 2017-06-28 2020-09-08 Ethicon Llc Method for articulating a surgical instrument
US10903685B2 (en) 2017-06-28 2021-01-26 Ethicon Llc Surgical shaft assemblies with slip ring assemblies forming capacitive channels
US11389161B2 (en) 2017-06-28 2022-07-19 Cilag Gmbh International Surgical instrument comprising selectively actuatable rotatable couplers
USD851762S1 (en) 2017-06-28 2019-06-18 Ethicon Llc Anvil
US10258418B2 (en) 2017-06-29 2019-04-16 Ethicon Llc System for controlling articulation forces
US11007022B2 (en) 2017-06-29 2021-05-18 Ethicon Llc Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument
US10398434B2 (en) 2017-06-29 2019-09-03 Ethicon Llc Closed loop velocity control of closure member for robotic surgical instrument
US10932772B2 (en) 2017-06-29 2021-03-02 Ethicon Llc Methods for closed loop velocity control for robotic surgical instrument
US10898183B2 (en) 2017-06-29 2021-01-26 Ethicon Llc Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing
US11304695B2 (en) 2017-08-03 2022-04-19 Cilag Gmbh International Surgical system shaft interconnection
US11471155B2 (en) 2017-08-03 2022-10-18 Cilag Gmbh International Surgical system bailout
USD907648S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
US11399829B2 (en) 2017-09-29 2022-08-02 Cilag Gmbh International Systems and methods of initiating a power shutdown mode for a surgical instrument
USD907647S1 (en) 2017-09-29 2021-01-12 Ethicon Llc Display screen or portion thereof with animated graphical user interface
USD917500S1 (en) 2017-09-29 2021-04-27 Ethicon Llc Display screen or portion thereof with graphical user interface
US10729501B2 (en) 2017-09-29 2020-08-04 Ethicon Llc Systems and methods for language selection of a surgical instrument
US10743872B2 (en) 2017-09-29 2020-08-18 Ethicon Llc System and methods for controlling a display of a surgical instrument
US10765429B2 (en) 2017-09-29 2020-09-08 Ethicon Llc Systems and methods for providing alerts according to the operational state of a surgical instrument
US10796471B2 (en) 2017-09-29 2020-10-06 Ethicon Llc Systems and methods of displaying a knife position for a surgical instrument
US11090075B2 (en) 2017-10-30 2021-08-17 Cilag Gmbh International Articulation features for surgical end effector
US11134944B2 (en) 2017-10-30 2021-10-05 Cilag Gmbh International Surgical stapler knife motion controls
US10842490B2 (en) 2017-10-31 2020-11-24 Ethicon Llc Cartridge body design with force reduction based on firing completion
US10779903B2 (en) 2017-10-31 2020-09-22 Ethicon Llc Positive shaft rotation lock activated by jaw closure
US10779825B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments
US11033267B2 (en) 2017-12-15 2021-06-15 Ethicon Llc Systems and methods of controlling a clamping member firing rate of a surgical instrument
US10687813B2 (en) 2017-12-15 2020-06-23 Ethicon Llc Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments
US11006955B2 (en) 2017-12-15 2021-05-18 Ethicon Llc End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments
US10779826B2 (en) 2017-12-15 2020-09-22 Ethicon Llc Methods of operating surgical end effectors
US10869666B2 (en) 2017-12-15 2020-12-22 Ethicon Llc Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument
US11071543B2 (en) 2017-12-15 2021-07-27 Cilag Gmbh International Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges
US11197670B2 (en) 2017-12-15 2021-12-14 Cilag Gmbh International Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed
US10966718B2 (en) 2017-12-15 2021-04-06 Ethicon Llc Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments
US10743874B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Sealed adapters for use with electromechanical surgical instruments
US10743875B2 (en) 2017-12-15 2020-08-18 Ethicon Llc Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member
US10828033B2 (en) 2017-12-15 2020-11-10 Ethicon Llc Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto
US10835330B2 (en) 2017-12-19 2020-11-17 Ethicon Llc Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly
US10729509B2 (en) 2017-12-19 2020-08-04 Ethicon Llc Surgical instrument comprising closure and firing locking mechanism
US11045270B2 (en) 2017-12-19 2021-06-29 Cilag Gmbh International Robotic attachment comprising exterior drive actuator
USD910847S1 (en) 2017-12-19 2021-02-16 Ethicon Llc Surgical instrument assembly
US10716565B2 (en) 2017-12-19 2020-07-21 Ethicon Llc Surgical instruments with dual articulation drivers
US11020112B2 (en) 2017-12-19 2021-06-01 Ethicon Llc Surgical tools configured for interchangeable use with different controller interfaces
US11076853B2 (en) 2017-12-21 2021-08-03 Cilag Gmbh International Systems and methods of displaying a knife position during transection for a surgical instrument
US11129680B2 (en) 2017-12-21 2021-09-28 Cilag Gmbh International Surgical instrument comprising a projector
US11311290B2 (en) 2017-12-21 2022-04-26 Cilag Gmbh International Surgical instrument comprising an end effector dampener
US10682134B2 (en) 2017-12-21 2020-06-16 Ethicon Llc Continuous use self-propelled stapling instrument
EP3502056A1 (en) * 2017-12-22 2019-06-26 Imertech Sas Co-synthesis of phyllominerals with metallic particles and products obtained therefrom
CN108066068A (en) * 2017-12-29 2018-05-25 广东川田卫生用品有限公司 A kind of sanitary napkin
WO2019155097A1 (en) * 2018-02-09 2019-08-15 Montesa Productos Cerámicos, S.A. Method for obtaining clay nanoparticles and product made from said clay nanoparticles
US10912559B2 (en) 2018-08-20 2021-02-09 Ethicon Llc Reinforced deformable anvil tip for surgical stapler anvil
US10842492B2 (en) 2018-08-20 2020-11-24 Ethicon Llc Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system
US10779821B2 (en) 2018-08-20 2020-09-22 Ethicon Llc Surgical stapler anvils with tissue stop features configured to avoid tissue pinch
US11039834B2 (en) 2018-08-20 2021-06-22 Cilag Gmbh International Surgical stapler anvils with staple directing protrusions and tissue stability features
US11207065B2 (en) 2018-08-20 2021-12-28 Cilag Gmbh International Method for fabricating surgical stapler anvils
USD914878S1 (en) 2018-08-20 2021-03-30 Ethicon Llc Surgical instrument anvil
US11253256B2 (en) 2018-08-20 2022-02-22 Cilag Gmbh International Articulatable motor powered surgical instruments with dedicated articulation motor arrangements
US10856870B2 (en) 2018-08-20 2020-12-08 Ethicon Llc Switching arrangements for motor powered articulatable surgical instruments
US11083458B2 (en) 2018-08-20 2021-08-10 Cilag Gmbh International Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions
US11324501B2 (en) 2018-08-20 2022-05-10 Cilag Gmbh International Surgical stapling devices with improved closure members
US11045192B2 (en) 2018-08-20 2021-06-29 Cilag Gmbh International Fabricating techniques for surgical stapler anvils
US11291440B2 (en) 2018-08-20 2022-04-05 Cilag Gmbh International Method for operating a powered articulatable surgical instrument
CN109200339B (en) * 2018-09-12 2021-03-05 华东理工大学 Composite material, raw material composition, bone restoration body, preparation method and application
WO2020065540A1 (en) * 2018-09-25 2020-04-02 Church & Dwight Co., Inc. Animal litters exhibiting enhanced odor reduction properties, and related methods
US11696761B2 (en) 2019-03-25 2023-07-11 Cilag Gmbh International Firing drive arrangements for surgical systems
US11147553B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11147551B2 (en) 2019-03-25 2021-10-19 Cilag Gmbh International Firing drive arrangements for surgical systems
US11172929B2 (en) 2019-03-25 2021-11-16 Cilag Gmbh International Articulation drive arrangements for surgical systems
US11648009B2 (en) 2019-04-30 2023-05-16 Cilag Gmbh International Rotatable jaw tip for a surgical instrument
US11253254B2 (en) 2019-04-30 2022-02-22 Cilag Gmbh International Shaft rotation actuator on a surgical instrument
US11471157B2 (en) 2019-04-30 2022-10-18 Cilag Gmbh International Articulation control mapping for a surgical instrument
US11452528B2 (en) 2019-04-30 2022-09-27 Cilag Gmbh International Articulation actuators for a surgical instrument
US11426251B2 (en) 2019-04-30 2022-08-30 Cilag Gmbh International Articulation directional lights on a surgical instrument
US11432816B2 (en) 2019-04-30 2022-09-06 Cilag Gmbh International Articulation pin for a surgical instrument
US11903581B2 (en) 2019-04-30 2024-02-20 Cilag Gmbh International Methods for stapling tissue using a surgical instrument
US11464601B2 (en) 2019-06-28 2022-10-11 Cilag Gmbh International Surgical instrument comprising an RFID system for tracking a movable component
US11627959B2 (en) 2019-06-28 2023-04-18 Cilag Gmbh International Surgical instruments including manual and powered system lockouts
US11259803B2 (en) 2019-06-28 2022-03-01 Cilag Gmbh International Surgical stapling system having an information encryption protocol
US11051807B2 (en) 2019-06-28 2021-07-06 Cilag Gmbh International Packaging assembly including a particulate trap
US11553971B2 (en) 2019-06-28 2023-01-17 Cilag Gmbh International Surgical RFID assemblies for display and communication
US11684434B2 (en) 2019-06-28 2023-06-27 Cilag Gmbh International Surgical RFID assemblies for instrument operational setting control
US11426167B2 (en) 2019-06-28 2022-08-30 Cilag Gmbh International Mechanisms for proper anvil attachment surgical stapling head assembly
US11219455B2 (en) 2019-06-28 2022-01-11 Cilag Gmbh International Surgical instrument including a lockout key
US11241235B2 (en) 2019-06-28 2022-02-08 Cilag Gmbh International Method of using multiple RFID chips with a surgical assembly
US11660163B2 (en) 2019-06-28 2023-05-30 Cilag Gmbh International Surgical system with RFID tags for updating motor assembly parameters
US11638587B2 (en) 2019-06-28 2023-05-02 Cilag Gmbh International RFID identification systems for surgical instruments
US11771419B2 (en) 2019-06-28 2023-10-03 Cilag Gmbh International Packaging for a replaceable component of a surgical stapling system
US11291451B2 (en) 2019-06-28 2022-04-05 Cilag Gmbh International Surgical instrument with battery compatibility verification functionality
US11523822B2 (en) 2019-06-28 2022-12-13 Cilag Gmbh International Battery pack including a circuit interrupter
US11376098B2 (en) 2019-06-28 2022-07-05 Cilag Gmbh International Surgical instrument system comprising an RFID system
US11224497B2 (en) 2019-06-28 2022-01-18 Cilag Gmbh International Surgical systems with multiple RFID tags
US11478241B2 (en) 2019-06-28 2022-10-25 Cilag Gmbh International Staple cartridge including projections
US11399837B2 (en) 2019-06-28 2022-08-02 Cilag Gmbh International Mechanisms for motor control adjustments of a motorized surgical instrument
US11298127B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Interational Surgical stapling system having a lockout mechanism for an incompatible cartridge
US11298132B2 (en) 2019-06-28 2022-04-12 Cilag GmbH Inlernational Staple cartridge including a honeycomb extension
US11246678B2 (en) 2019-06-28 2022-02-15 Cilag Gmbh International Surgical stapling system having a frangible RFID tag
US11497492B2 (en) 2019-06-28 2022-11-15 Cilag Gmbh International Surgical instrument including an articulation lock
US11559304B2 (en) 2019-12-19 2023-01-24 Cilag Gmbh International Surgical instrument comprising a rapid closure mechanism
US11304696B2 (en) 2019-12-19 2022-04-19 Cilag Gmbh International Surgical instrument comprising a powered articulation system
US11607219B2 (en) 2019-12-19 2023-03-21 Cilag Gmbh International Staple cartridge comprising a detachable tissue cutting knife
US11529137B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Staple cartridge comprising driver retention members
US11576672B2 (en) 2019-12-19 2023-02-14 Cilag Gmbh International Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw
US11291447B2 (en) 2019-12-19 2022-04-05 Cilag Gmbh International Stapling instrument comprising independent jaw closing and staple firing systems
US11529139B2 (en) 2019-12-19 2022-12-20 Cilag Gmbh International Motor driven surgical instrument
US11464512B2 (en) 2019-12-19 2022-10-11 Cilag Gmbh International Staple cartridge comprising a curved deck surface
US11844520B2 (en) 2019-12-19 2023-12-19 Cilag Gmbh International Staple cartridge comprising driver retention members
US11701111B2 (en) 2019-12-19 2023-07-18 Cilag Gmbh International Method for operating a surgical stapling instrument
US11911032B2 (en) 2019-12-19 2024-02-27 Cilag Gmbh International Staple cartridge comprising a seating cam
US11446029B2 (en) 2019-12-19 2022-09-20 Cilag Gmbh International Staple cartridge comprising projections extending from a curved deck surface
US11234698B2 (en) 2019-12-19 2022-02-01 Cilag Gmbh International Stapling system comprising a clamp lockout and a firing lockout
US11504122B2 (en) 2019-12-19 2022-11-22 Cilag Gmbh International Surgical instrument comprising a nested firing member
US11337421B2 (en) * 2019-12-24 2022-05-24 Hamed Ahari Method for producing antimicrobial nanofilms packaging cover based on Titanium nano-dioxide through extrusion for extension of food shelf-life
USD975851S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD975850S1 (en) 2020-06-02 2023-01-17 Cilag Gmbh International Staple cartridge
USD974560S1 (en) 2020-06-02 2023-01-03 Cilag Gmbh International Staple cartridge
USD976401S1 (en) 2020-06-02 2023-01-24 Cilag Gmbh International Staple cartridge
USD967421S1 (en) 2020-06-02 2022-10-18 Cilag Gmbh International Staple cartridge
USD966512S1 (en) 2020-06-02 2022-10-11 Cilag Gmbh International Staple cartridge
USD975278S1 (en) 2020-06-02 2023-01-10 Cilag Gmbh International Staple cartridge
US11737748B2 (en) 2020-07-28 2023-08-29 Cilag Gmbh International Surgical instruments with double spherical articulation joints with pivotable links
CN112006032B (en) * 2020-08-31 2021-06-11 中国科学院地球环境研究所 Preparation method of intercalation type metal oxide antibacterial agent
US11534259B2 (en) 2020-10-29 2022-12-27 Cilag Gmbh International Surgical instrument comprising an articulation indicator
US11896217B2 (en) 2020-10-29 2024-02-13 Cilag Gmbh International Surgical instrument comprising an articulation lock
US11617577B2 (en) 2020-10-29 2023-04-04 Cilag Gmbh International Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable
US11452526B2 (en) 2020-10-29 2022-09-27 Cilag Gmbh International Surgical instrument comprising a staged voltage regulation start-up system
US11779330B2 (en) 2020-10-29 2023-10-10 Cilag Gmbh International Surgical instrument comprising a jaw alignment system
USD1013170S1 (en) 2020-10-29 2024-01-30 Cilag Gmbh International Surgical instrument assembly
US11517390B2 (en) 2020-10-29 2022-12-06 Cilag Gmbh International Surgical instrument comprising a limited travel switch
USD980425S1 (en) 2020-10-29 2023-03-07 Cilag Gmbh International Surgical instrument assembly
US11717289B2 (en) 2020-10-29 2023-08-08 Cilag Gmbh International Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable
US11844518B2 (en) 2020-10-29 2023-12-19 Cilag Gmbh International Method for operating a surgical instrument
US11678882B2 (en) 2020-12-02 2023-06-20 Cilag Gmbh International Surgical instruments with interactive features to remedy incidental sled movements
US11849943B2 (en) 2020-12-02 2023-12-26 Cilag Gmbh International Surgical instrument with cartridge release mechanisms
US11627960B2 (en) 2020-12-02 2023-04-18 Cilag Gmbh International Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections
US11890010B2 (en) 2020-12-02 2024-02-06 Cllag GmbH International Dual-sided reinforced reload for surgical instruments
US11653915B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Surgical instruments with sled location detection and adjustment features
US11744581B2 (en) 2020-12-02 2023-09-05 Cilag Gmbh International Powered surgical instruments with multi-phase tissue treatment
US11737751B2 (en) 2020-12-02 2023-08-29 Cilag Gmbh International Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings
US11653920B2 (en) 2020-12-02 2023-05-23 Cilag Gmbh International Powered surgical instruments with communication interfaces through sterile barrier
US11744583B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Distal communication array to tune frequency of RF systems
US11812964B2 (en) 2021-02-26 2023-11-14 Cilag Gmbh International Staple cartridge comprising a power management circuit
US11793514B2 (en) 2021-02-26 2023-10-24 Cilag Gmbh International Staple cartridge comprising sensor array which may be embedded in cartridge body
US11701113B2 (en) 2021-02-26 2023-07-18 Cilag Gmbh International Stapling instrument comprising a separate power antenna and a data transfer antenna
US11730473B2 (en) 2021-02-26 2023-08-22 Cilag Gmbh International Monitoring of manufacturing life-cycle
US11696757B2 (en) 2021-02-26 2023-07-11 Cilag Gmbh International Monitoring of internal systems to detect and track cartridge motion status
US11751869B2 (en) 2021-02-26 2023-09-12 Cilag Gmbh International Monitoring of multiple sensors over time to detect moving characteristics of tissue
US11749877B2 (en) 2021-02-26 2023-09-05 Cilag Gmbh International Stapling instrument comprising a signal antenna
US11723657B2 (en) 2021-02-26 2023-08-15 Cilag Gmbh International Adjustable communication based on available bandwidth and power capacity
US11737749B2 (en) 2021-03-22 2023-08-29 Cilag Gmbh International Surgical stapling instrument comprising a retraction system
US11806011B2 (en) 2021-03-22 2023-11-07 Cilag Gmbh International Stapling instrument comprising tissue compression systems
US11717291B2 (en) 2021-03-22 2023-08-08 Cilag Gmbh International Staple cartridge comprising staples configured to apply different tissue compression
US11826042B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Surgical instrument comprising a firing drive including a selectable leverage mechanism
US11759202B2 (en) 2021-03-22 2023-09-19 Cilag Gmbh International Staple cartridge comprising an implantable layer
US11826012B2 (en) 2021-03-22 2023-11-28 Cilag Gmbh International Stapling instrument comprising a pulsed motor-driven firing rack
US11723658B2 (en) 2021-03-22 2023-08-15 Cilag Gmbh International Staple cartridge comprising a firing lockout
US11744603B2 (en) 2021-03-24 2023-09-05 Cilag Gmbh International Multi-axis pivot joints for surgical instruments and methods for manufacturing same
US11786239B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Surgical instrument articulation joint arrangements comprising multiple moving linkage features
US11896219B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Mating features between drivers and underside of a cartridge deck
US11849945B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Rotary-driven surgical stapling assembly comprising eccentrically driven firing member
US11849944B2 (en) 2021-03-24 2023-12-26 Cilag Gmbh International Drivers for fastener cartridge assemblies having rotary drive screws
US11832816B2 (en) 2021-03-24 2023-12-05 Cilag Gmbh International Surgical stapling assembly comprising nonplanar staples and planar staples
US11793516B2 (en) 2021-03-24 2023-10-24 Cilag Gmbh International Surgical staple cartridge comprising longitudinal support beam
US11786243B2 (en) 2021-03-24 2023-10-17 Cilag Gmbh International Firing members having flexible portions for adapting to a load during a surgical firing stroke
US11903582B2 (en) 2021-03-24 2024-02-20 Cilag Gmbh International Leveraging surfaces for cartridge installation
US11896218B2 (en) 2021-03-24 2024-02-13 Cilag Gmbh International Method of using a powered stapling device
US11857183B2 (en) 2021-03-24 2024-01-02 Cilag Gmbh International Stapling assembly components having metal substrates and plastic bodies
US11826047B2 (en) 2021-05-28 2023-11-28 Cilag Gmbh International Stapling instrument comprising jaw mounts
WO2023044022A1 (en) * 2021-09-16 2023-03-23 Cupron Inc. Fibers with embedded particles and methods of producing fibers with embedded particles
US11877745B2 (en) 2021-10-18 2024-01-23 Cilag Gmbh International Surgical stapling assembly having longitudinally-repeating staple leg clusters
CN114405486B (en) * 2021-11-17 2023-06-23 重庆科技学院 Preparation method of porous cryogel with antifouling and antibacterial functions and dye adsorption preventing functions
CN115521422B (en) * 2022-10-24 2023-10-24 上海大学 Method for preparing polyacrylate Pickering composite emulsion by edge modification of lithium magnesium silicate

Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US449978A (en) * 1891-04-07 Oliver sweeney
US3440181A (en) * 1965-03-22 1969-04-22 Dow Chemical Co Metal coated vermicular expanded graphite and polymer composition containing same
US4589876A (en) * 1983-07-05 1986-05-20 The Procter & Gamble Company Sanitary napkin
US4608047A (en) * 1985-05-28 1986-08-26 Personal Products Company Sanitary napkin attachment means
US4640810A (en) * 1984-06-12 1987-02-03 Scan Web Of North America, Inc. System for producing an air laid web
US4687478A (en) * 1984-03-20 1987-08-18 The Procter & Gamble Company Shaped sanitary napkin with flaps
US4739007A (en) * 1985-09-30 1988-04-19 Kabushiki Kaisha Toyota Chou Kenkyusho Composite material and process for manufacturing same
US4900320A (en) * 1986-06-16 1990-02-13 Mcneil-Ppc, Inc. Sanitary napkin with panty gathering flaps
US5143954A (en) * 1990-11-27 1992-09-01 Rohm And Haas Company Low-formaldehyde, self-crosslinking polymer latex composition
US5415926A (en) * 1993-02-25 1995-05-16 National Starch And Chemical Investment Holding Corporation Process for reducing the free aldehyde content in N-alkylol amide monomers
JPH07173022A (en) * 1993-12-17 1995-07-11 Asahi Chem Ind Co Ltd Antimicrobial agent
US5576282A (en) * 1995-09-11 1996-11-19 The Procter & Gamble Company Color-safe bleach boosters, compositions and laundry methods employing same
US5707950A (en) * 1994-11-18 1998-01-13 The Procter & Gamble Company Detergent compositions containing lipase and protease
US5866242A (en) * 1997-01-17 1999-02-02 Rayonier Inc. Soft, strong, absorbent material for use in absorbent articles
US5869033A (en) * 1996-04-12 1999-02-09 Enviroderm Pharmaceuticals,Inc. Method of preventing skin irritation caused by fecal enzymes
US5885516A (en) * 1994-09-06 1999-03-23 Scan-Web I/S Method and a system for manufacturing broad airlaid paper webs containing an absorbing powder
US5985169A (en) * 1997-05-23 1999-11-16 W.R. Grace & Co.-Conn. Oxygen scavenging metal-loaded high surface area particulate compositions
US20020055580A1 (en) * 2000-09-21 2002-05-09 Lorah Dennis Paul High acid aqueous nanocomposite dispersions
US20020150678A1 (en) * 2001-01-30 2002-10-17 Cramer Ronald Dean Method of applying nanoparticles
US6482192B2 (en) * 2000-12-19 2002-11-19 Mcneil-Ppc, Inc. Discrete absorbent articles
US6492453B1 (en) * 1999-09-24 2002-12-10 Alphagary Corporation Low smoke emission, low corrosivity, low toxicity, low heat release, flame retardant, zero halogen polymeric compositions
US6518324B1 (en) * 2000-11-28 2003-02-11 Atofina Chemicals, Inc. Polymer foam containing nanoclay
US20030114822A1 (en) * 2001-12-19 2003-06-19 Collando Santos H. Drapeable absorbent article
US20030185964A1 (en) * 2002-03-28 2003-10-02 Jan Weber Method for spray-coating a medical device having a tubular wall such as a stent
US20030203009A1 (en) * 2002-04-30 2003-10-30 Macdonald John Gavin Metal ion modified high surface area materials for odor removal and control
US20040175386A1 (en) * 2001-06-29 2004-09-09 Norinobu Yoshikawa Composite powders and skin preparations for external use containing the same
US20050074413A1 (en) * 2001-05-31 2005-04-07 Emmanuelle Belli Aerosol composition comprising silicate particles and surfactants
US7005408B2 (en) * 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7169348B2 (en) * 2001-07-06 2007-01-30 University Of Queensland Method of making metal oxide nanoparticles in an exfoliated silicate framework
US7988799B2 (en) * 2005-08-22 2011-08-02 United Technologies Corporation Welding repair method for full hoop structures

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US598169A (en) * 1898-02-01 Hook and eye
US4449978A (en) * 1981-08-31 1984-05-22 Air Products And Chemicals, Inc. Nonwoven products having low residual free formaldehyde content
US20050013759A1 (en) * 1996-08-14 2005-01-20 Grow Ann E. Practical method for preparing inorganic nanophase materials
JPH10182142A (en) 1996-10-23 1998-07-07 Osaki Kogyo Kk Metallic fine particle/solid carrier composition, its use and production
MXPA01005692A (en) * 1998-12-07 2002-04-24 Eastman Chem Co A polymer/clay nanocomposite having improved gas barrier comprising a clay material with a mixture of two or more organic cations and a process for preparing same.
EP1066825A1 (en) * 1999-06-17 2001-01-10 The Procter & Gamble Company An anti-microbial body care product
JP3911235B2 (en) * 2000-09-21 2007-05-09 ローム アンド ハース カンパニー Modified nanocomposite composition and methods of making and using the same
US7183345B2 (en) * 2001-06-29 2007-02-27 Stockhausen Gmbh Superabsorbent carboxyl-containing polymers with odor control properties and method for preparation
CN2512413Y (en) * 2001-11-01 2002-09-25 上海兰格科技有限公司 Antiseptic high absorption composite material
US6974492B2 (en) * 2002-11-26 2005-12-13 Honda Motor Co., Ltd. Method for synthesis of metal nanoparticles
US7776425B2 (en) * 2003-01-21 2010-08-17 The Penn State Research Foundation Nanoparticle coated nanostructured surfaces for detection, catalysis and device applications

Patent Citations (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US449978A (en) * 1891-04-07 Oliver sweeney
US3440181A (en) * 1965-03-22 1969-04-22 Dow Chemical Co Metal coated vermicular expanded graphite and polymer composition containing same
US4589876B1 (en) * 1983-07-05 1993-04-27 Procter & Gamble
US4589876A (en) * 1983-07-05 1986-05-20 The Procter & Gamble Company Sanitary napkin
US4687478A (en) * 1984-03-20 1987-08-18 The Procter & Gamble Company Shaped sanitary napkin with flaps
US4640810A (en) * 1984-06-12 1987-02-03 Scan Web Of North America, Inc. System for producing an air laid web
US4608047A (en) * 1985-05-28 1986-08-26 Personal Products Company Sanitary napkin attachment means
US4739007A (en) * 1985-09-30 1988-04-19 Kabushiki Kaisha Toyota Chou Kenkyusho Composite material and process for manufacturing same
US4900320A (en) * 1986-06-16 1990-02-13 Mcneil-Ppc, Inc. Sanitary napkin with panty gathering flaps
US4900320C1 (en) * 1986-06-16 2001-07-03 Mcneil Ppc Inc Sanitary napkin with panty gathering flaps
US5143954A (en) * 1990-11-27 1992-09-01 Rohm And Haas Company Low-formaldehyde, self-crosslinking polymer latex composition
US5415926A (en) * 1993-02-25 1995-05-16 National Starch And Chemical Investment Holding Corporation Process for reducing the free aldehyde content in N-alkylol amide monomers
JPH07173022A (en) * 1993-12-17 1995-07-11 Asahi Chem Ind Co Ltd Antimicrobial agent
US5885516A (en) * 1994-09-06 1999-03-23 Scan-Web I/S Method and a system for manufacturing broad airlaid paper webs containing an absorbing powder
US5707950A (en) * 1994-11-18 1998-01-13 The Procter & Gamble Company Detergent compositions containing lipase and protease
US5576282A (en) * 1995-09-11 1996-11-19 The Procter & Gamble Company Color-safe bleach boosters, compositions and laundry methods employing same
US5869033A (en) * 1996-04-12 1999-02-09 Enviroderm Pharmaceuticals,Inc. Method of preventing skin irritation caused by fecal enzymes
US5866242A (en) * 1997-01-17 1999-02-02 Rayonier Inc. Soft, strong, absorbent material for use in absorbent articles
US5985169A (en) * 1997-05-23 1999-11-16 W.R. Grace & Co.-Conn. Oxygen scavenging metal-loaded high surface area particulate compositions
US6492453B1 (en) * 1999-09-24 2002-12-10 Alphagary Corporation Low smoke emission, low corrosivity, low toxicity, low heat release, flame retardant, zero halogen polymeric compositions
US20020055580A1 (en) * 2000-09-21 2002-05-09 Lorah Dennis Paul High acid aqueous nanocomposite dispersions
US6518324B1 (en) * 2000-11-28 2003-02-11 Atofina Chemicals, Inc. Polymer foam containing nanoclay
US6497690B2 (en) * 2000-12-19 2002-12-24 Mcneil-Ppc, Inc. Descrete absorbent articles
US6482192B2 (en) * 2000-12-19 2002-11-19 Mcneil-Ppc, Inc. Discrete absorbent articles
US20020150678A1 (en) * 2001-01-30 2002-10-17 Cramer Ronald Dean Method of applying nanoparticles
US20050074413A1 (en) * 2001-05-31 2005-04-07 Emmanuelle Belli Aerosol composition comprising silicate particles and surfactants
US20040175386A1 (en) * 2001-06-29 2004-09-09 Norinobu Yoshikawa Composite powders and skin preparations for external use containing the same
US7169348B2 (en) * 2001-07-06 2007-01-30 University Of Queensland Method of making metal oxide nanoparticles in an exfoliated silicate framework
US20030114822A1 (en) * 2001-12-19 2003-06-19 Collando Santos H. Drapeable absorbent article
US20030185964A1 (en) * 2002-03-28 2003-10-02 Jan Weber Method for spray-coating a medical device having a tubular wall such as a stent
US20030203009A1 (en) * 2002-04-30 2003-10-30 Macdonald John Gavin Metal ion modified high surface area materials for odor removal and control
US7005408B2 (en) * 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7285517B2 (en) * 2002-05-01 2007-10-23 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7758887B2 (en) * 2002-05-01 2010-07-20 McNeil - PPC Warming and nonirritating lubricant compositions and method of comparing irritation
US7988799B2 (en) * 2005-08-22 2011-08-02 United Technologies Corporation Welding repair method for full hoop structures

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Jun et al, Preparation of Highdispersed Nanosilver/Montmorillonite Composites and Their Characterization, Chinese Journal of Inorganic Chemistry, Vol. 20, No. 3, March 2004, pp 321-323. *
Rao et al, Nanoparticles of nickel and silver produced by the polyol reduction of the metal salts intercalated in montmorillonite, Solid State Ionics, Vol. 84, (1996), pp 271-281. *
Yu et al, Deposition of silver nanoparticles on montmorillonite platelets by chemical plating, Journal of Materials Science, Vol. 37 (2002), pp 5083-5087. *

Cited By (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119689A1 (en) * 2001-09-24 2003-06-26 Hutton Howard David Cleaning composition
US8475689B2 (en) 2003-06-30 2013-07-02 Johnson & Johnson Consumer Companies, Inc. Topical composition containing galvanic particulates
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US9302033B2 (en) 2005-12-14 2016-04-05 Bsn Medical Gmbh Wound treatment device with elastically deformable vacuum producing element
US20080306456A1 (en) * 2005-12-14 2008-12-11 Birgit Riesinger Wound Treatment Device with Elastically Deformable Vacuum-Generating Element
US20080269186A1 (en) * 2006-04-24 2008-10-30 Carlo Alberto Bignozzi Functional Nanomaterials With Antibacterial and Antiviral Activity
US8158137B2 (en) * 2006-04-24 2012-04-17 NM Tech Nanomaterials and Microdevices Technology Limited Functional nanomaterials with antibacterial and antiviral activity
US20080058738A1 (en) * 2006-08-31 2008-03-06 Kimberly-Clark Worldwide, Inc. Derivatized expanded starch for odor control
US20080058739A1 (en) * 2006-08-31 2008-03-06 Kimberly-Clark Worldwide, Inc. Expanded starch for odor control
US20090302280A1 (en) * 2006-10-06 2009-12-10 General Electric Company Composition and associated method
US7632425B1 (en) 2006-10-06 2009-12-15 General Electric Company Composition and associated method
US20080085962A1 (en) * 2006-10-06 2008-04-10 General Electric Company Composition and associated method
US20080085410A1 (en) * 2006-10-06 2008-04-10 General Electric Company Composition and associated method
WO2008055049A3 (en) * 2006-10-30 2008-10-02 Mcneil Ppc Inc Enzyme inhibition using nanoparticles
US20080103459A1 (en) * 2006-10-30 2008-05-01 Anthony Di Salvo Enzyme inhibition using nanoparticles
WO2008068418A2 (en) * 2006-11-15 2008-06-12 Skin'up Textile and/or fiber processing method using an active ingredient composed of nanoparticles<0}
WO2008068418A3 (en) * 2006-11-15 2008-07-24 Skin Up Textile and/or fiber processing method using an active ingredient composed of nanoparticles<0}
US20100136325A1 (en) * 2006-11-27 2010-06-03 Reddy Ganta S Antimicrobial materials and coatings
US9376771B2 (en) * 2006-11-27 2016-06-28 Mhi Health Devices, Llc Antimicrobial materials and coatings
US20100196294A1 (en) * 2007-01-26 2010-08-05 Coty Inc. Coatings for mammalian nails that include nanosized particles
US20080229612A1 (en) * 2007-03-22 2008-09-25 Poshpeds Incorporated Human wearable laminar structure, insole made therefrom and methods for their manufacture
EP2659896A2 (en) 2007-09-28 2013-11-06 Johnson & Johnson Consumer Companies Inc. Electricity-generating particulates and the use thereof
WO2009045720A2 (en) 2007-09-28 2009-04-09 Johnson & Johnson Consumer Companies, Inc. Electricity-generating particulates and the use thereof
EP2754445A2 (en) 2007-09-28 2014-07-16 Johnson & Johnson Consumer Companies Inc. Electricity-generating particulates for use in excessive sweating
US20090092836A1 (en) * 2007-10-04 2009-04-09 Gwamgju Institute Of Science And Technology Gold nanoparticle-halloysite nanotube and method of forming the same
EP2206503A1 (en) * 2007-10-05 2010-07-14 Universidad De Santiago De Compostela Use of atomic quantum clusters (aqc) as antimicrobial agents and biocides
EP2206503A4 (en) * 2007-10-05 2011-09-07 Univ Santiago Compostela Use of atomic quantum clusters (aqc) as antimicrobial agents and biocides
US20090104434A1 (en) * 2007-10-17 2009-04-23 Jennifer Hoyt Lalli Conformal multifunctional coatings
US20090148484A1 (en) * 2007-12-07 2009-06-11 National Taiwan University Stably-dispersing composite of metal nanoparticle and inorganic clay and method for producing the same
US20100004588A1 (en) * 2008-07-01 2010-01-07 Baxter International Inc. Nanoclay sorbents for dialysis
US11097041B2 (en) 2008-07-01 2021-08-24 Baxter International Inc. Nanoclay sorbent methods for use with dialysis
US9821105B2 (en) 2008-07-01 2017-11-21 Baxter International Inc. Nanoclay sorbents for dialysis
US10342912B2 (en) 2008-07-01 2019-07-09 Baxter International Inc. Nanoclay sorbents for dialysis
WO2010111511A1 (en) * 2009-03-27 2010-09-30 Johnson & Johnson Consumer Companies, Inc. Binary and tertiary galvanic particulates and methods of manufacturing and use thereof
WO2010111502A3 (en) * 2009-03-27 2011-03-10 Ethicon, Inc. Medical devices with galvanic particulates
WO2010111502A2 (en) 2009-03-27 2010-09-30 Ethicon, Inc. Medical devices with galvanic particulates
US9044397B2 (en) 2009-03-27 2015-06-02 Ethicon, Inc. Medical devices with galvanic particulates
US20120183626A1 (en) * 2009-09-24 2012-07-19 Vladimir Ilych Barbakov Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application
WO2011035989A3 (en) * 2009-09-24 2011-06-23 Closed Stock Company "Institute Of Applied Nanotechnology" Method of processing a thread especially for medical uses
WO2011035988A1 (en) * 2009-09-24 2011-03-31 Closed Stock Company "Institute Of Applied Nanotechnology" Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application
EP2353578A2 (en) 2010-02-05 2011-08-10 Johnson & Johnson Consumer Companies, Inc. Lip compositions comprising galvanic particulates
WO2011109259A1 (en) 2010-03-01 2011-09-09 Johnson & Johnson Consumer Companies, Inc. Skin care composition having desirable bulk color
WO2011130112A1 (en) 2010-04-16 2011-10-20 Ethicon, Inc. Medical devices with galvanic particulates
WO2011131422A1 (en) * 2010-04-20 2011-10-27 Closed Stock Company "Institute Of Applied Nanotechnology" Toilet soap with antimicrobic properties
WO2011160860A1 (en) * 2010-06-21 2011-12-29 Closed Stock Company "Institute Of Applied Nanotechnology" Compositions for antiseptic processing of woven materials
WO2012006526A2 (en) 2010-07-08 2012-01-12 Johnson & Johnson Consumer Companies, Inc. Skin care emulsion composition
US8906418B1 (en) 2010-08-27 2014-12-09 Sienna Labs, Inc. Thermal treatment of a pilosebaceous unit with nanoparticles with coatings that facilitate selective removal from the skin surface
US10537640B2 (en) 2010-08-27 2020-01-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
US8834933B2 (en) 2010-08-27 2014-09-16 Sienna Labs, Inc. Thermal treatment of acne with nanoparticles
US8895071B1 (en) 2010-08-27 2014-11-25 Sienna Labs, Inc. Thermal treatment of a pilosebaceous unit with coated metal nanoparticles
US8821941B2 (en) 2010-08-27 2014-09-02 Sienna Labs, Inc. Hair removal with nanoparticles
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
US8802154B2 (en) 2010-08-27 2014-08-12 Sienna Labs, Inc. Thermal treatment of a pilosebaceous unit with nanoparticles
US9061056B2 (en) 2010-08-27 2015-06-23 Sienna Labs, Inc. Compositions and methods for targeted thermomodulation
AU2011293132B2 (en) * 2010-08-27 2015-11-26 Sebacia, Inc. Compositions and methods for targeted thermomodulation
US11826087B2 (en) 2010-08-27 2023-11-28 Coronado Aesthetics, Llc Compositions and methods for thermal skin treatment with metal nanoparticles
US11419937B2 (en) 2010-08-27 2022-08-23 Coronado Aesthetics, Llc Delivery of nanoparticles
WO2012027728A3 (en) * 2010-08-27 2012-06-14 Sienna Labs, Inc. Compositions and methods for targeted thermomodulation
US9446126B2 (en) 2010-08-27 2016-09-20 Sienna Biopharmaceuticals, Inc. Thermal treatment of acne with coated metal nanoparticles
AU2011293132C1 (en) * 2010-08-27 2016-04-21 Sebacia, Inc. Compositions and methods for targeted thermomodulation
US8821940B2 (en) 2010-08-27 2014-09-02 Sienna Labs, Inc. Thermal treatment of the skin surface with nanoparticles
US9439964B2 (en) 2010-08-27 2016-09-13 Sienna Biopharmaceuticals, Inc. Thermal treatment of the skin surface with coated metal nanoparticles
US9439965B2 (en) 2010-08-27 2016-09-13 Sienna Biopharmaceuticals, Inc. Thermal treatment of the skin surface with metal nanoparticles in surfactant containing solutions
US9421259B2 (en) 2010-08-27 2016-08-23 Sienna Biopharmaceuticals, Inc. Hair removal with coated metal nanoparticles
US9421261B2 (en) 2010-08-27 2016-08-23 Sienna Biopharmaceuticals, Inc. Thermal treatment of the skin surface with nanoparticles with coatings that facilitate selective removal from the skin surface
US9421260B2 (en) 2010-08-27 2016-08-23 Sienna Biopharmaceuticals, Inc. Thermal treatment of acne with nanoparticles with coatings that facilitate selective removal from the skin surface
US9427467B2 (en) 2010-08-27 2016-08-30 Sienna Biopharmaceuticals, Inc. Hair removal with metal nanoparticles in surfactant containing solutions
US9433676B2 (en) 2010-08-27 2016-09-06 Sienna Biopharmaceuticals, Inc. Hair removal with nanoparticles with coatings that facilitate selective removal from the skin surface
US9433678B2 (en) 2010-08-27 2016-09-06 Sienna Biopharmaceuticals, Inc. Thermal treatment of acne with metal nanoparticles in surfactant containing solutions
US9433677B2 (en) 2010-08-27 2016-09-06 Sienna Biopharmaceuticals, Inc. Thermal treatment of a pilosebaceous unit with metal nanoparticles in surfactant containing solutions
WO2012028340A1 (en) * 2010-08-31 2012-03-08 Closed Stock Company "Institute Of Applied Nanotechnology" Preventive ointment for diabetic foot
WO2012044538A1 (en) 2010-09-27 2012-04-05 Advanced Technologies And Regenerative Medicine, Llc Medical devices with galvanic particulates
WO2012173312A1 (en) * 2011-06-17 2012-12-20 부산대학교 산학협력단 Cosmetic composition for preventing skin aging, containing as an active ingredient gold nanoparticles surface-treated with phytochemicals
KR101333209B1 (en) 2011-06-17 2013-11-26 부산대학교 산학협력단 Cosmetic composition for preventing skin aging comprising surface-modified gold nanoparticle by phytochemical
EP3064228A1 (en) 2011-12-21 2016-09-07 Ethicon. Inc. Hemostatic materials and devices with galvanic particulates
US9028851B2 (en) 2011-12-21 2015-05-12 Ethicon, Inc. Hemostatic materials and devices with galvanic particulates
US9624973B2 (en) * 2012-03-19 2017-04-18 Samsung Electronics Co., Ltd. Apparatus having friction preventing function and method of manufacturing the same
US9333258B2 (en) 2012-05-08 2016-05-10 The Regents Of The University Of California Fine spatiotemporal control of fat removal using NIR light
US11628010B2 (en) 2012-05-08 2023-04-18 The Regents Of The University Of California Selective fat removal using photothermal heating
US10188461B2 (en) 2012-05-08 2019-01-29 The Regents Of The University Of California Selective fat removal using photothermal heating
US9522289B2 (en) 2012-05-08 2016-12-20 The Regents Of The University Of California Selective fat removal using photothermal heating
US9333259B2 (en) 2012-05-08 2016-05-10 The Regents Of The University Of California Selective fat removal using NIR light and nanoparticles
US9249334B2 (en) 2012-10-11 2016-02-02 Nanocomposix, Inc. Silver nanoplate compositions and methods
US9526745B2 (en) 2012-10-11 2016-12-27 Nanocomposix, Inc. Silver nanoplate compositions and methods
US11583553B2 (en) 2012-10-11 2023-02-21 Nanocomposix, Llc Silver nanoplate compositions and methods
US9212294B2 (en) 2012-10-11 2015-12-15 Nanocomposix, Inc. Silver nanoplate compositions and methods
US10688126B2 (en) 2012-10-11 2020-06-23 Nanocomposix, Inc. Silver nanoplate compositions and methods
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039619B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11464232B2 (en) 2014-02-19 2022-10-11 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11470847B2 (en) 2014-02-19 2022-10-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11751570B2 (en) 2014-02-19 2023-09-12 Corning Incorporated Aluminosilicate glass with phosphorus and potassium
WO2015184347A1 (en) * 2014-05-29 2015-12-03 Metabeauty, Inc. Methods and compositions for the use of silver to prevent and treat acne
US10150932B2 (en) 2016-07-22 2018-12-11 United Technologies Corporation Auxiliary emergency protective lubrication system for metal mechanical components
US10035969B2 (en) * 2016-07-22 2018-07-31 United Technologies Corporation Auxiliary emergency protective lubrication system for metal mechanical components
US10087320B2 (en) 2017-02-17 2018-10-02 Polydrop, Llc Conductive polymer-matrix compositions and uses thereof
US11491265B2 (en) 2017-02-22 2022-11-08 Cornell University Mechanical vacuum dressing for mechanically managing, protecting and suctioning small incisional wounds
US11839527B2 (en) 2017-12-06 2023-12-12 Cornell University Manually-operated negative pressure wound therapy (NPWT) bandage with improved pump efficiency, automatic pressure indicator and automatic pressure limiter

Also Published As

Publication number Publication date
JP2007519767A (en) 2007-07-19
DE602004015134D1 (en) 2008-08-28
DE602004016022D1 (en) 2008-10-02
EP1682193A1 (en) 2006-07-26
JP2007519615A (en) 2007-07-19
US20050115462A1 (en) 2005-06-02
BRPI0416114A (en) 2007-01-02
CN1925879B (en) 2011-07-13
AU2004285579B2 (en) 2011-02-10
ATE405300T1 (en) 2008-09-15
ES2311879T3 (en) 2009-02-16
CN1925879A (en) 2007-03-07
CA2544109A1 (en) 2005-05-12
EP1682193B1 (en) 2008-07-16
EP1677843B1 (en) 2008-08-20
AU2004285579A1 (en) 2005-05-12
WO2005042041A1 (en) 2005-05-12
BRPI0415633A (en) 2006-12-12
EP1677843A1 (en) 2006-07-12
CA2544119A1 (en) 2005-05-12
BRPI0415633B1 (en) 2014-03-04
AU2004285578A1 (en) 2005-05-12
US7988779B2 (en) 2011-08-02
US20130189334A1 (en) 2013-07-25
WO2005042040A1 (en) 2005-05-12
CA2544109C (en) 2012-05-29
CN1925880A (en) 2007-03-07
ATE401100T1 (en) 2008-08-15
CN100594944C (en) 2010-03-24
CA2544119C (en) 2012-05-29
AU2004285578B2 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
AU2004285579B2 (en) Composite materials comprising metal-loaded nanoparticles
AU2005337071B2 (en) Absorbent article comprising a thin film including an active agent
EP2480499B1 (en) Biocidal colloidal dispersions of silica particles with silver ions adsorbed thereon
US9192625B1 (en) Antimicrobial nanocomposite compositions, fibers and films
JPS6323960A (en) High molecular material containing amorphous aluminosilicate particle and production thereof
EP2083796B1 (en) Metal coated nanoparticles for use in the treatment of enzymatic dermatitis
MXPA06004819A (en) Composite materials comprising metal-loaded nanoparticles
Sohani et al. Use of nanocomposites in drug delivery systems
Topalić-Trivunović et al. Antibacterial finishing of textile materials using modified bentonite
Latif et al. Antimicrobial Applications of Clay Nanotube-Based Composites
JP2648282B2 (en) Fungicide for MRSA
Shanmugam et al. Exploring the effect of one-dimensional halloysite based bionanocomposite hydrogel for bone regeneration
MXPA06004821A (en) Absorbent articles comprising metal-loaded nanoparticles

Legal Events

Date Code Title Description
AS Assignment

Owner name: MCNEIL-PPC, INC., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DISALVO, ANTHONY L.;MORDAS, CAROLYN J.;REEL/FRAME:016476/0513

Effective date: 20050414

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: NANO MET-ZERO, INC., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DISALVO, ANTHONY L.;REEL/FRAME:031706/0712

Effective date: 20131008

Owner name: DISALVO, ANTHONY L., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MCNEIL-PPC, INC.;REEL/FRAME:031706/0487

Effective date: 20130917